Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYH9 IPO8 CENPE MYO9A ZGRF1 KIF1B ABCC11 CHD9 MSH3 ABCA10 ABCG1 MLH3 MYH14 NAV2 ACIN1 SMC1B	1.88e-05	614	152	16	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal protein binding	TPR MYH9 ANK2 ANK3 MAP1B MAP2 CENPE MYO9A SYNE1 ATCAY KIF1B CEP290 CCDC88C STX1A BRCA1 MYH14 SIPA1L1 RP1 SSH2 PLS1 VCL	9.15e-05	1099	152	21	GO:0008092
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	TPR MYH9 SLK CDC42BPA ANK3 MAP1B MAP2 CENPE CEP290 DRC1 CNTLN ODF2 TTK CNTROB AXIN1 CCDC88C AKAP9 BRCA1 MAP7D2 RP1 USP33 JHY	1.61e-08	720	152	22	GO:0000226
GeneOntologyBiologicalProcess	microtubule-based process	TPR MYH9 SLK CDC42BPA ANK3 MAP1B MAP2 CENPE KIF1B CEP290 DRC1 CNTLN ODF2 TTK CNTROB AXIN1 CCDC88C AKAP9 BRCA1 MAP7D2 RP1 USP33 JHY	3.07e-06	1058	152	23	GO:0007017
GeneOntologyBiologicalProcess	organelle localization	STX2 MYH9 CDC42BPA MAP1B MAP2 CENPE SYNE1 ATCAY KIF1B CEP290 FAM91A1 STX1B STX1A AKAP9 WDR11 PLD2	6.47e-05	703	152	16	GO:0051640
GeneOntologyBiologicalProcess	negative regulation of organelle organization	TPR MYH9 MAP1B MAP2 CENPE XRCC4 TTK CCDC88C BRCA1 RP1 CGNL1 SSH2	6.95e-05	421	152	12	GO:0010639
GeneOntologyCellularComponent	costamere	ANK2 ANK3 CMYA5 VCL	1.68e-05	22	150	4	GO:0043034
GeneOntologyCellularComponent	growth cone	DSCAM MAP1B RASGRF1 MAP2 MYO9A ATCAY NEO1 MYH14 CTNND1	7.13e-05	245	150	9	GO:0030426
GeneOntologyCellularComponent	glutamatergic synapse	PRUNE2 MAP1B MAP2 MYO9A CARMIL3 PPFIA4 DOCK10 DAPK1 CHRM2 SLC17A5 STX1A NEO1 AKAP9 SIPA1L1 SCN10A SEPTIN11 CTNND1	8.18e-05	817	150	17	GO:0098978
GeneOntologyCellularComponent	site of polarized growth	DSCAM MAP1B RASGRF1 MAP2 MYO9A ATCAY NEO1 MYH14 CTNND1	9.11e-05	253	150	9	GO:0030427
GeneOntologyCellularComponent	postsynapse	ANK2 ANK3 MAP1B MAP2 MYO9A CARMIL3 SYNE1 KIF1B DOCK10 DAPK1 CHRM2 SLC1A3 STX1A NEO1 AKAP9 SIPA1L1 SEPTIN11 CTNND1 GABRR3	1.28e-04	1018	150	19	GO:0098794
GeneOntologyCellularComponent	myosin II filament	MYH9 MYH14	1.53e-04	3	150	2	GO:0097513
GeneOntologyCellularComponent	Set1C/COMPASS complex	SETD1A ASH2L BOD1L1	1.89e-04	16	150	3	GO:0048188
GeneOntologyCellularComponent	actomyosin	MYH9 CDC42BPA STX1A MYH14 SEPTIN11 VCL	2.01e-04	117	150	6	GO:0042641
GeneOntologyCellularComponent	actin cytoskeleton	MYH9 CDC42BPA MAP2 MYO9A ANKRD26 DAPK1 STX1A MYH14 SIPA1L1 SEPTIN11 CGNL1 PLS1 VCL	2.70e-04	576	150	13	GO:0015629
GeneOntologyCellularComponent	lateral element	BRCA1 SYCP1 SMC1B	3.23e-04	19	150	3	GO:0000800
GeneOntologyCellularComponent	synaptonemal complex	MLH3 BRCA1 SYCP1 SMC1B	3.29e-04	46	150	4	GO:0000795
GeneOntologyCellularComponent	synaptonemal structure	MLH3 BRCA1 SYCP1 SMC1B	3.29e-04	46	150	4	GO:0099086
GeneOntologyCellularComponent	neuron to neuron synapse	ANK2 ANK3 MAP1B MAP2 DAPK1 CHRM2 STX1A NEO1 AKAP9 SIPA1L1 SEPTIN11 CTNND1	4.02e-04	523	150	12	GO:0098984
GeneOntologyCellularComponent	somatodendritic compartment	ANK3 DSCAM MAP1B RASGRF1 MAP2 SYNE1 ATCAY KIF1B DOCK10 CHRM2 SLC1A3 AKAP12 NEO1 AKAP9 LNPEP SIPA1L1 SEPTIN11 ASTN1 CTNND1 USP33	5.04e-04	1228	150	20	GO:0036477
GeneOntologyCellularComponent	asymmetric synapse	ANK2 ANK3 MAP1B MAP2 DAPK1 CHRM2 STX1A NEO1 AKAP9 SIPA1L1 CTNND1	6.74e-04	477	150	11	GO:0032279
GeneOntologyCellularComponent	axon	ANK3 DSCAM MAP1B RASGRF1 MAP2 MYO9A ATCAY KIF1B CHRM2 STX1B STX1A NEO1 MYH14 SCN10A SEPTIN11 CTNND1	6.83e-04	891	150	16	GO:0030424
GeneOntologyCellularComponent	myosin complex	MYH9 MYO9A MYH14 CGNL1	8.53e-04	59	150	4	GO:0016459
GeneOntologyCellularComponent	postsynaptic specialization	ANK2 ANK3 MAP1B MAP2 DAPK1 STX1A NEO1 AKAP9 SIPA1L1 SEPTIN11 CTNND1	1.04e-03	503	150	11	GO:0099572
GeneOntologyCellularComponent	dendritic branch	MAP2 AKAP9	1.05e-03	7	150	2	GO:0044307
GeneOntologyCellularComponent	microtubule associated complex	TPR MAP1B MAP2 KIF1B DRC1 RP1	1.09e-03	161	150	6	GO:0005875
GeneOntologyCellularComponent	distal axon	DSCAM MAP1B RASGRF1 MAP2 MYO9A ATCAY CHRM2 NEO1 MYH14 CTNND1	1.21e-03	435	150	10	GO:0150034
GeneOntologyCellularComponent	dendrite	ANK3 DSCAM MAP1B RASGRF1 MAP2 SYNE1 ATCAY KIF1B DOCK10 CHRM2 SLC1A3 AKAP9 SIPA1L1 SEPTIN11 CTNND1	1.32e-03	858	150	15	GO:0030425
GeneOntologyCellularComponent	dendritic tree	ANK3 DSCAM MAP1B RASGRF1 MAP2 SYNE1 ATCAY KIF1B DOCK10 CHRM2 SLC1A3 AKAP9 SIPA1L1 SEPTIN11 CTNND1	1.35e-03	860	150	15	GO:0097447
GeneOntologyCellularComponent	lamellipodium	STX2 MYH9 CDC42BPA CARMIL3 MCC PLD2 CTNND1	1.39e-03	230	150	7	GO:0030027
GeneOntologyCellularComponent	VCB complex	CUL2 USP33	1.39e-03	8	150	2	GO:0030891
GeneOntologyCellularComponent	apical dendrite	MAP1B RASGRF1 MAP2	1.54e-03	32	150	3	GO:0097440
GeneOntologyCellularComponent	postsynaptic density	ANK2 ANK3 MAP1B MAP2 DAPK1 STX1A NEO1 AKAP9 SIPA1L1 CTNND1	1.58e-03	451	150	10	GO:0014069
GeneOntologyCellularComponent	actin filament bundle	MYH9 MYH14 SEPTIN11 PLS1 VCL	1.62e-03	118	150	5	GO:0032432
GeneOntologyCellularComponent	condensed chromosome	TPR CENPE XRCC4 TTK MLH3 BRCA1 SYCP1 SMC1B	1.72e-03	307	150	8	GO:0000793
GeneOntologyCellularComponent	dendritic spine	MAP1B SYNE1 DOCK10 SLC1A3 SIPA1L1 SEPTIN11 CTNND1	1.85e-03	242	150	7	GO:0043197
GeneOntologyCellularComponent	neuron spine	MAP1B SYNE1 DOCK10 SLC1A3 SIPA1L1 SEPTIN11 CTNND1	2.08e-03	247	150	7	GO:0044309
GeneOntologyCellularComponent	histone methyltransferase complex	SETD1A ASH2L KMT2C BOD1L1	2.09e-03	75	150	4	GO:0035097
GeneOntologyCellularComponent	basal dendrite	MAP1B MAP2	2.22e-03	10	150	2	GO:0097441
GeneOntologyCellularComponent	laminin complex	LAMB1 LAMB3	2.22e-03	10	150	2	GO:0043256
GeneOntologyCellularComponent	mismatch repair complex	MSH3 MLH3	2.70e-03	11	150	2	GO:0032300
GeneOntologyCellularComponent	MLL3/4 complex	ASH2L KMT2C	3.22e-03	12	150	2	GO:0044666
GeneOntologyCellularComponent	synaptic membrane	STX2 ANK2 ANK3 SYNE1 CHRM2 STX1B STX1A NEO1 AKAP9 SCN10A GABRR3	3.28e-03	583	150	11	GO:0097060
GeneOntologyCellularComponent	presynaptic active zone	STX2 PPFIA4 STX1B STX1A CTNND1	3.52e-03	141	150	5	GO:0048786
GeneOntologyCellularComponent	symmetric synapse	CHRM2 SEPTIN11	3.79e-03	13	150	2	GO:0032280
GeneOntologyCellularComponent	nucleotide-excision repair complex	ERCC5 XRCC4	3.79e-03	13	150	2	GO:0000109
GeneOntologyCellularComponent	condensed nuclear chromosome	MLH3 BRCA1 SYCP1 SMC1B	4.20e-03	91	150	4	GO:0000794
GeneOntologyCellularComponent	cytoplasmic ubiquitin ligase complex	CUL2 USP33	4.40e-03	14	150	2	GO:0000153
Domain	-	GTF2IRD2B GTF2I GTF2IRD2	2.02e-06	4	150	3	3.90.1460.10
Domain	GTF2I	GTF2IRD2B GTF2I GTF2IRD2	2.02e-06	4	150	3	PS51139
Domain	GTF2I	GTF2IRD2B GTF2I GTF2IRD2	2.02e-06	4	150	3	PF02946
Domain	GTF2I	GTF2IRD2B GTF2I GTF2IRD2	2.02e-06	4	150	3	IPR004212
Domain	SynN	STX2 STX1B STX1A	4.12e-05	9	150	3	SM00503
Domain	STX1A/1B	STX1B STX1A	6.41e-05	2	150	2	IPR028669
Domain	Syntaxin	STX2 STX1B STX1A	7.99e-05	11	150	3	PF00804
Domain	Syntaxin_N	STX2 STX1B STX1A	1.06e-04	12	150	3	IPR006011
Domain	Syntaxin/epimorphin_CS	STX2 STX1B STX1A	2.63e-04	16	150	3	IPR006012
Domain	SYNTAXIN	STX2 STX1B STX1A	2.63e-04	16	150	3	PS00914
Domain	IQ	MYH9 RASGRF1 MYO9A MYH14 SCN10A	2.66e-04	71	150	5	PF00612
Domain	Myosin_tail_1	MYH9 MYH14 CGNL1	3.79e-04	18	150	3	PF01576
Domain	Myosin_tail	MYH9 MYH14 CGNL1	3.79e-04	18	150	3	IPR002928
Domain	Bcl2-/adenovirus-E1B	PRUNE2 ATCAY	3.80e-04	4	150	2	IPR022181
Domain	BNIP2	PRUNE2 ATCAY	3.80e-04	4	150	2	PF12496
Domain	t-SNARE	STX2 STX1B STX1A AMOTL2	3.87e-04	43	150	4	IPR010989
Domain	P-loop_NTPase	MYH9 CENPE MYO9A ZGRF1 KIF1B ABCC11 DAPK1 CHD9 MSH3 SLFN5 ABCA10 ABCG1 MYH14 NAV2 SEPTIN11 RAB37 SMC1B	4.73e-04	848	150	17	IPR027417
Domain	SNARE	STX2 STX1B STX1A	6.07e-04	21	150	3	PF05739
Domain	ABC_transporter-like	ABCC11 ABCA10 ABCG1 SMC1B	6.91e-04	50	150	4	IPR003439
Domain	t_SNARE	STX2 STX1B STX1A	6.99e-04	22	150	3	SM00397
Domain	IQ_motif_EF-hand-BS	MYH9 RASGRF1 MYO9A MYH14 SCN10A	7.94e-04	90	150	5	IPR000048
Domain	IQ	MYH9 RASGRF1 MYO9A MYH14 SCN10A	9.21e-04	93	150	5	PS50096
Domain	Myb-like_dom	DMTF1 GON4L	9.41e-04	6	150	2	IPR017877
Domain	T_SNARE	STX2 STX1B STX1A	1.15e-03	26	150	3	PS50192
Domain	DEATH	ANK2 ANK3 DAPK1	1.29e-03	27	150	3	SM00005
Domain	T_SNARE_dom	STX2 STX1B STX1A	1.59e-03	29	150	3	IPR000727
Domain	SAND_dom	SP110 GMEB1	1.74e-03	8	150	2	IPR000770
Domain	SAND	SP110 GMEB1	1.74e-03	8	150	2	PF01342
Domain	SAND	SP110 GMEB1	1.74e-03	8	150	2	PS50864
Domain	SAND	SP110 GMEB1	1.74e-03	8	150	2	SM00258
Domain	CH	SYNE1 EHBP1L1 NAV2 PLS1	1.85e-03	65	150	4	SM00033
Domain	ZU5	ANK2 ANK3	2.22e-03	9	150	2	SM00218
Domain	Death	ANK2 ANK3 DAPK1	2.32e-03	33	150	3	PF00531
Domain	CH	SYNE1 EHBP1L1 NAV2 PLS1	2.43e-03	70	150	4	PF00307
Domain	-	SYNE1 EHBP1L1 NAV2 PLS1	2.56e-03	71	150	4	1.10.418.10
Domain	Prefoldin	TPR LAMB1 KRT24 RNF20	2.69e-03	72	150	4	IPR009053
Domain	ZU5	ANK2 ANK3	2.76e-03	10	150	2	PS51145
Domain	CH	SYNE1 EHBP1L1 NAV2 PLS1	2.83e-03	73	150	4	PS50021
Domain	CH-domain	SYNE1 EHBP1L1 NAV2 PLS1	3.12e-03	75	150	4	IPR001715
Domain	DHR-1_domain	DOCK4 DOCK10	3.36e-03	11	150	2	IPR027007
Domain	DHR_2	DOCK4 DOCK10	3.36e-03	11	150	2	PS51651
Domain	DHR_1	DOCK4 DOCK10	3.36e-03	11	150	2	PS51650
Domain	DHR-2	DOCK4 DOCK10	3.36e-03	11	150	2	PF06920
Domain	DOCK	DOCK4 DOCK10	3.36e-03	11	150	2	IPR026791
Domain	DOCK_C	DOCK4 DOCK10	3.36e-03	11	150	2	IPR010703
Domain	DOCK-C2	DOCK4 DOCK10	3.36e-03	11	150	2	PF14429
Domain	DHR-2	DOCK4 DOCK10	3.36e-03	11	150	2	IPR027357
Domain	Myosin_head_motor_dom	MYH9 MYO9A MYH14	3.49e-03	38	150	3	IPR001609
Domain	MYOSIN_MOTOR	MYH9 MYO9A MYH14	3.49e-03	38	150	3	PS51456
Domain	Death_domain	ANK2 ANK3 DAPK1	3.49e-03	38	150	3	IPR000488
Domain	DEATH_DOMAIN	ANK2 ANK3 DAPK1	3.49e-03	38	150	3	PS50017
Domain	Myosin_head	MYH9 MYO9A MYH14	3.49e-03	38	150	3	PF00063
Domain	MYSc	MYH9 MYO9A MYH14	3.49e-03	38	150	3	SM00242
Domain	FN3	DSCAM CMYA5 KIAA0319 SNED1 NEO1 ASTN1	3.84e-03	185	150	6	SM00060
Domain	-	SP110 GMEB1	4.01e-03	12	150	2	3.10.390.10
Domain	CRAL_TRIO_2	PRUNE2 ATCAY	4.01e-03	12	150	2	PF13716
Domain	ZU5	ANK2 ANK3	4.01e-03	12	150	2	PF00791
Domain	ZU5_dom	ANK2 ANK3	4.01e-03	12	150	2	IPR000906
Domain	SAND_dom-like	SP110 GMEB1	4.01e-03	12	150	2	IPR010919
Domain	IQ	MYH9 RASGRF1 MYO9A MYH14	4.12e-03	81	150	4	SM00015
Domain	ABC_transporter_CS	ABCC11 ABCA10 ABCG1	4.63e-03	42	150	3	IPR017871
Domain	Myosin_N	MYH9 MYH14	6.28e-03	15	150	2	PF02736
Domain	Myosin_N	MYH9 MYH14	6.28e-03	15	150	2	IPR004009
Domain	ABC_tran	ABCC11 ABCA10 ABCG1	6.74e-03	48	150	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCC11 ABCA10 ABCG1	6.74e-03	48	150	3	PS50893
Domain	FN3_dom	DSCAM CMYA5 KIAA0319 SNED1 NEO1 ASTN1	6.90e-03	209	150	6	IPR003961
Domain	ABC_TRANSPORTER_1	ABCC11 ABCA10 ABCG1	7.14e-03	49	150	3	PS00211
Domain	Post-SET_dom	SETD1A KMT2C	7.14e-03	16	150	2	IPR003616
Domain	PostSET	SETD1A KMT2C	7.14e-03	16	150	2	SM00508
Domain	Laminin_N	LAMB1 LAMB3	7.14e-03	16	150	2	IPR008211
Domain	LamNT	LAMB1 LAMB3	7.14e-03	16	150	2	SM00136
Domain	LAMININ_NTER	LAMB1 LAMB3	7.14e-03	16	150	2	PS51117
Domain	Laminin_N	LAMB1 LAMB3	7.14e-03	16	150	2	PF00055
Domain	POST_SET	SETD1A KMT2C	7.14e-03	16	150	2	PS50868
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 HIVEP2 CDC42BPA MAP1B MAP2 MYO9A KIF1B ANKRD26 CCDC6 MDM4 TTK CIC CCDC88C NEK1 AKAP9 SIPA1L1 NAV2 BOD1L1 CGNL1 SSH2 CTNND1 GOLGB1	3.49e-11	861	153	22	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 UBR2 SLK TRO SYNE1 KIF1B DOCK10 GON4L FAM91A1 WASHC2A KIAA0319 AKAP9 SIPA1L1 ACIN1 BOD1L1 USP33	4.10e-11	407	153	16	12693553
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DOCK4 IPO8 CENPE KIF1B CEP290 ANKRD26 FAM91A1 PATL1 CNTLN ODF2 WASHC2A TTK CCDC88C WDR11 WDCP SIPA1L1 MAP7D2 TMEM131 CGNL1 PDZRN3 VCL	1.99e-10	853	153	21	28718761
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR GPRASP1 MYH9 SLK ANK2 ANK3 DSCAM CENPE SYNE1 MCC DAPK1 CCDC6 SLC1A3 AKAP12 KIAA0319 CCDC88C AKAP9 SIPA1L1 SEPTIN11 SSH2 CTNND1 GOLGB1	2.90e-10	963	153	22	28671696
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GPRASP1 HIVEP2 ANK2 ANK3 DSCAM KDM4C SYNE1 KIF1B CEP290 LAMB1 CHD9 SMG5 MSH3 ODF2 CCDC6 CMYA5 STX1A MYH14 SIPA1L1 ASTN1 TMEM131 AMOTL2 USP33 ZNF662	2.31e-09	1285	153	24	35914814
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMIM24 MYH9 ERCC5 ANK2 MAP1B TRO PPFIA4 SYNE1 BAG1 ANKRD26 ODF2 DNTTIP2 CAPN11 GTF2IRD2B CLCN5 BRCA1 MYH14 SYCP1 GTF2IRD2 NAV2 MAP7D2 ACIN1 BOD1L1 PLS1 GOLGB1	4.60e-09	1442	153	25	35575683
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	CDC42BPA ANK2 SYNE1 KIF1B ANKRD26 GON4L CMYA5 ASH2L DNTTIP2 AKAP12 PARP4 NEO1 AKAP9 MYH14 VCL	6.27e-09	497	153	15	23414517
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRUNE2 UBR2 CPAMD8 HIVEP2 ZBTB20 CDC42BPA ANK3 MAP1B MAP2 MYO9A UVSSA KIF1B CHD9 PATL1 MDM4 PACS1 KMT2C ABCG1 GTF2I WDR11 MYH14 SEPTIN11 BOD1L1 CTNND1 GOLGB1	8.69e-09	1489	153	25	28611215
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DMTF1 TPR ERCC5 ANK3 FAM91A1 PATL1 WASHC2A SLC1A3 ASH2L DNTTIP2 AKAP12 PACS1 KMT2C PSME4 SIPA1L1 VCAN SEPTIN11 ACIN1 BOD1L1 TMEM131 GOLGB1	1.37e-08	1084	153	21	11544199
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PRUNE2 UBR2 SETD1A CEP290 CHD9 CIC KIAA0319 CTNND1	2.10e-08	104	153	8	9205841
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	CUL2 SLK MAP1B DOCK10 GON4L LAMB3 FAM91A1 PATL1 ASH2L PACS1 PARP4 PSME4 WDR11 WDCP RNF20 USP33	3.32e-08	650	153	16	38777146
Pubmed	A human MAP kinase interactome.	TPR MYH9 HIVEP2 CDC42BPA ANK3 MYO9A SYNE1 CEP290 LAMB1 CIC KMT2C NAV2 CGNL1 GOLGB1	3.67e-08	486	153	14	20936779
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CUL2 CDC42BPA IPO8 ANK2 ANK3 MAP2 SYNE1 BAG1 ANKRD26 LAMB1 WASHC2A TTK DNTTIP2 AKAP12 NEO1 AKAP9 WDR11 LNPEP MAP7D2 TMEM131 CTNND1 GOLGB1 VCL USP33	3.77e-08	1487	153	24	33957083
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	TPR MYH9 SLK FAM91A1 PATL1 TTK WDR11 SEPTIN11 CTNND1 VCL	4.59e-08	216	153	10	31519766
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 CENPE MYO9A ZGRF1 KIF1B ANKRD26 CNTLN CCDC6 MDM4 WASHC2A TTK CIC WDCP CGNL1 GOLGB1	5.74e-08	588	153	15	38580884
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR MYH9 SLK KIF1B MSH3 CCDC6 AKAP12 PACS1 EHBP1L1 RNF20 ACIN1 GOLGB1	7.53e-08	360	153	12	33111431
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYH9 SLK ANK2 ANK3 MAP1B MAP2 MYO9A PPFIA4 SYNE1 KIF1B DAPK1 SLC1A3 STX1B PACS1 MYH14 SIPA1L1 VCAN SEPTIN11 MAP7D2 CGNL1 SSH2 CTNND1 VCL	8.07e-08	1431	153	23	37142655
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	TPR CDC42BPA CENPE ZGRF1 SYNE1 GON4L GTF2I SYCP1 CGNL1 GOLGB1	9.71e-08	234	153	10	36243803
Pubmed	A protein interaction landscape of breast cancer.	DOCK4 CUL2 TPR UBR2 ANK3 LAMB3 SMG5 MSH3 BRCA1 RNF20 NAV2 ACIN1 TRMT1L CTNND1 AMOTL2	1.52e-07	634	153	15	34591612
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DOCK4 TPR GPRASP1 MYH9 CDC42BPA ANK2 ANK3 MAP1B MAP2 FAM91A1 WASHC2A SLC1A3 STX1B STX1A NEO1 SIPA1L1 SEPTIN11 MAP7D2 ASTN1 CTNND1	1.53e-07	1139	153	20	36417873
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR SETD1A SLK ANK3 MAP1B ASH2L KMT2C NEK1 GTF2I ACIN1 BOD1L1 CTNND1 AMOTL2 VCL	1.63e-07	549	153	14	38280479
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	CUL2 TPR UBR2 SETD1A MYH9 CHD9 ASH2L AKAP12 PARP4 BRCA1 MYH14 PRPF39 VCL	3.22e-07	494	153	13	26831064
Pubmed	Evolution of general transcription factors.	GTF2IRD2B GTF2I GTF2IRD2	3.33e-07	4	153	3	23229069
Pubmed	GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members.	GTF2IRD2B GTF2I GTF2IRD2	3.33e-07	4	153	3	22899722
Pubmed	TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.	GTF2IRD2B GTF2I GTF2IRD2	3.33e-07	4	153	3	17823943
Pubmed	Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.	GTF2IRD2B GTF2I GTF2IRD2	3.33e-07	4	153	3	21328569
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	MYH9 CDC42BPA ANK3 DSCAM KIF1B ANKRD26 MUC16 FAM91A1 AKAP12 NEO1 GTF2I BRCA1 WDR11 CGNL1 CTNND1 GOLGB1	3.69e-07	777	153	16	35844135
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	MYO9A DOCK10 CHD9 CCDC88C KMT2C SIPA1L1 BOD1L1 RP1 GOLGB1	3.90e-07	208	153	9	33230847
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	TPR MYH9 WASHC2A TTK CIC GTF2I RNF20 SEPTIN11 ACIN1 BOD1L1 PLS1 GOLGB1 VCL	4.23e-07	506	153	13	30890647
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	DOCK4 GCFC2 IPO8 MAP1B CEP290 INTS1 CIC AKAP12 KMT2C NEK1 EHBP1L1 AKAP9 RNF20 SEPTIN11 SSH2	4.35e-07	689	153	15	36543142
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PRUNE2 CUL2 MYH9 SLK MAP2 KIF1B BAG1 LAMB1 CCDC6 CMYA5 WASHC2A AKAP12 EHBP1L1 GTF2I PSME4 MYH14 LNPEP RNF20 SEPTIN11 PRPF39 PLS1 VCL	4.48e-07	1455	153	22	22863883
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	TPR MYH9 CDC42BPA ANK2 ANK3 MAP1B MYO9A KIF1B ANKRD26 TTK AKAP12 BOD1L1 CTNND1 GOLGB1 VCL	6.12e-07	708	153	15	39231216
Pubmed	Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome".	STX2 MAP2 AKAP9 SMC1B	6.29e-07	16	153	4	29878059
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	TPR MYH9 SLK ANK2 FAM91A1 WASHC2A TTK AKAP12 LNPEP CTNND1 GOLGB1 USP33	7.93e-07	449	153	12	31732153
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SLK MAP1B ANKRD26 SMG5 PATL1 WASHC2A TTK AKAP12 PARP4 BRCA1 MYH14 SEPTIN11 TMEM131 CTNND1 VCL	8.09e-07	724	153	15	36232890
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR MYH9 SLK ANK2 MAP1B ANKRD26 CIC DNTTIP2 AKAP12 NEK1 GTF2I ACIN1 BOD1L1 CGNL1 CTNND1 GOLGB1 VCL	8.62e-07	934	153	17	33916271
Pubmed	Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.	KIF1B MSH3 CTCFL BRCA1	1.33e-06	19	153	4	14578343
Pubmed	Characterization of neogenin-expressing neural progenitor populations and migrating neuroblasts in the embryonic mouse forebrain.	MAP2 SLC1A3 NEO1	1.65e-06	6	153	3	16908105
Pubmed	Synaptotagmin VI and VIII and syntaxin 2 are essential for the mouse sperm acrosome reaction.	STX2 STX1B STX1A	1.65e-06	6	153	3	15774481
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	HIVEP2 MAP2 MYO9A INTS1 MCC KMT2C PSME4 SCN10A CTNND1 AMOTL2	1.80e-06	322	153	10	26514267
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR EXO5 GCFC2 ERCC5 KIF1B FAM91A1 PATL1 ODF2 CCDC6 CIC PACS1 GTF2I SIPA1L1 RNF20 ACIN1	1.84e-06	774	153	15	15302935
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PRUNE2 KDM4C PPFIA4 CEP290 ANKRD26 CCDC88C NEK1 PARP4 WDR11 CGNL1 SSH2 PDZRN3	2.09e-06	493	153	12	15368895
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	SETD1A ASH2L KMT2C BOD1L1	2.48e-06	22	153	4	26886794
Pubmed	Neogenin is expressed on neurogenic and gliogenic progenitors in the embryonic and adult central nervous system.	MAP2 SLC1A3 NEO1	2.88e-06	7	153	3	17604699
Pubmed	MUNC18-1 gene abnormalities are involved in neurodevelopmental disorders through defective cortical architecture during brain development.	STX1B STX1A SEPTIN11	2.88e-06	7	153	3	29191246
Pubmed	Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin.	STX2 STX1B STX1A	2.88e-06	7	153	3	8999968
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MYO9A CCDC6 WASHC2A AXIN1 NEK1 SIPA1L1 CTNND1 VCL	4.36e-06	209	153	8	36779422
Pubmed	Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.	ERCC5 MSH3 XRCC4 PARP4 BRCA1	4.50e-06	55	153	5	19536092
Pubmed	TBC1D23 is a bridging factor for endosomal vesicle capture by golgins at the trans-Golgi.	FAM91A1 WASHC2A WDR11	4.60e-06	8	153	3	29084197
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	MYH9 SLK GCFC2 MAP1B WASHC2A GTF2I MAP7D2 TRMT1L	5.37e-06	215	153	8	35973513
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TPR UBR2 MAP1B TRO ABHD10 SMG5 MSH3 MDM4 ASH2L CIC IRF9 TOMM40 TRMT1L CTNND1 PRPF39	6.30e-06	857	153	15	25609649
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	SETD1A ASH2L KMT2C	6.88e-06	9	153	3	22665483
Pubmed	BRCA1-mediated chromatin silencing is limited to oocytes with a small number of asynapsed chromosomes.	BRCA1 SYCP1 SMC1B	6.88e-06	9	153	3	19531582
Pubmed	Syntaxin isoform specificity in the regulation of renal H+-ATPase exocytosis.	STX2 STX1B STX1A	6.88e-06	9	153	3	12651853
Pubmed	Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers.	ERCC5 MSH3 MLH3	9.79e-06	10	153	3	17494052
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	TPR UBR2 MYH9 CDC42BPA KIF1B LAMB1 CHD9 PATL1 AXIN1 AKAP9 MYH14 SIPA1L1 SEPTIN11 ACIN1 TRMT1L CTNND1 AMOTL2 VCL	1.02e-05	1247	153	18	27684187
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	CARMIL3 CEP290 PROCA1 LAMB3 MSH3 CCDC6 CMYA5 BTN3A2 ADGRL4 SLC41A2 CCDC83 SYCP1 PDZRN3	1.17e-05	686	153	13	29987050
Pubmed	Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.	ERCC5 MSH3 XRCC4 MLH3 BRCA1	1.29e-05	68	153	5	20496165
Pubmed	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	DMTF1 ANK3 SYNE1	1.34e-05	11	153	3	20351715
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	TPR MAP1B SNED1 SEPTIN11 CTNND1 GOLGB1	1.44e-05	118	153	6	30979931
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	TPR MYH9 CDC42BPA MAP1B KIF1B CHD9 AXIN1 GTF2I WDR11 SEPTIN11 MAP7D2 ACIN1 BOD1L1 PRPF39	1.48e-05	809	153	14	32129710
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	CUL2 GPRASP1 MYH9 GCFC2 MYO9A CEP290 CHD9 C11orf24 MDM4 TTK CNTROB SLC41A2 GTF2IRD2B STX1A AMOTL2	1.55e-05	925	153	15	28986522
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	GCFC2 ERCC5 IPO8 TRO PPFIA4 LAMB1 XRCC4 BEND2 CNTROB CIC BRCA1 MYH14	1.73e-05	608	153	12	16713569
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	SETD1A ASH2L KMT2C	1.78e-05	12	153	3	27563068
Pubmed	Human transcription factor protein interaction networks.	CUL2 SETD1A SLK CDC42BPA GON4L SMG5 PATL1 WASHC2A ASH2L CIC IRF9 KMT2C GTF2I BRCA1 MYH14 WDCP GMEB1 TRMT1L VCL	1.80e-05	1429	153	19	35140242
Pubmed	BOD1L mediates chromatin binding and non-canonical function of H3K4 methyltransferase SETD1A.	SETD1A BOD1L1	1.92e-05	2	153	2	38989615
Pubmed	HPC-1/syntaxin 1A and syntaxin 1B play distinct roles in neuronal survival.	STX1B STX1A	1.92e-05	2	153	2	24666284
Pubmed	Titration of Syntaxin1 in mammalian synapses reveals multiple roles in vesicle docking, priming, and release probability.	STX1B STX1A	1.92e-05	2	153	2	24133272
Pubmed	A conserved role for Syntaxin-1 in pre- and post-commissural midline axonal guidance in fly, chick, and mouse.	STX1B STX1A	1.92e-05	2	153	2	29912942
Pubmed	Degradation of Caytaxin Causes Learning and Memory Deficits via Activation of DAPK1 in Aging.	ATCAY DAPK1	1.92e-05	2	153	2	30120735
Pubmed	DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice.	ZBTB20 BRCA1	1.92e-05	2	153	2	26615780
Pubmed	Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related Thrombocytopenia and MYH9-related diseases.	MYH9 ANKRD26	1.92e-05	2	153	2	29545013
Pubmed	Multifunctional transcription factor TFII-I is an activator of BRCA1 function.	GTF2I BRCA1	1.92e-05	2	153	2	21407215
Pubmed	ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.	ABCG1 CSF2	1.92e-05	2	153	2	17848583
Pubmed	BAG1 over-expression in brain protects against stroke.	MAP2 BAG1	1.92e-05	2	153	2	14655755
Pubmed	Tetrodotoxin-resistant voltage-gated sodium channel Nav 1.8 constitutively interacts with ankyrin G.	ANK3 SCN10A	1.92e-05	2	153	2	24903831
Pubmed	Syntaxin 1B, but not syntaxin 1A, is necessary for the regulation of synaptic vesicle exocytosis and of the readily releasable pool at central synapses.	STX1B STX1A	1.92e-05	2	153	2	24587181
Pubmed	Syntaxin-1A modulates vesicle fusion in mammalian neurons via juxtamembrane domain dependent palmitoylation of its transmembrane domain.	STX1B STX1A	1.92e-05	2	153	2	35638903
Pubmed	Homology with vesicle fusion mediator syntaxin-1a predicts determinants of epimorphin/syntaxin-2 function in mammary epithelial morphogenesis.	STX2 STX1A	1.92e-05	2	153	2	19129200
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	1.92e-05	2	153	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	1.92e-05	2	153	2	25383926
Pubmed	Neogenin regulates neuronal survival through DAP kinase.	DAPK1 NEO1	1.92e-05	2	153	2	18583991
Pubmed	Microsecond dissection of neurotransmitter release: SNARE-complex assembly dictates speed and Ca²⁺ sensitivity.	STX1B STX1A	1.92e-05	2	153	2	24908488
Pubmed	Distinct roles of nonmuscle myosin II isoforms for establishing tension and elasticity during cell morphodynamics.	MYH9 MYH14	1.92e-05	2	153	2	34374341
Pubmed	DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing.	MAP1B DAPK1	1.92e-05	2	153	2	18195017
Pubmed	Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.	GTF2IRD2B GTF2IRD2	1.92e-05	2	153	2	15388857
Pubmed	ZNF212 promotes genomic integrity through direct interaction with TRAIP.	TPR CNTROB RNF20 GOLGB1	2.12e-05	37	153	4	36594163
Pubmed	Dynamic patterns of histone H3 lysine 4 methyltransferases and demethylases during mouse preimplantation development.	SETD1A ASH2L KMT2C	2.31e-05	13	153	3	24619213
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GCFC2 CENPE CEP290 MCC PATL1 WASHC2A NEO1 BOD1L1 TMEM131 CTNND1 PDZRN3 VCL USP33	2.34e-05	733	153	13	34672954
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MYH9 CENPE CEP290 INTS1 LAMB3 C11orf24 SLFN5 KMT2C PARP4 BOD1L1 PWWP3B AMOTL2 PLS1	2.44e-05	736	153	13	29676528
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD1A CCDC6 ASH2L DNTTIP2 GTF2I MYH14 WDCP RNF20 TRMT1L CTNND1	2.73e-05	440	153	10	34244565
Pubmed	PTK7 regulates myosin II activity to orient planar polarity in the mammalian auditory epithelium.	MYH9 MYH14 VCL	2.93e-05	14	153	3	22560610
Pubmed	Phosphorylation of chromosome core components may serve as axis marks for the status of chromosomal events during mammalian meiosis.	BRCA1 SYCP1 SMC1B	2.93e-05	14	153	3	22346761
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYH9 MYO9A MYH14	2.93e-05	14	153	3	8022818
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	SLK MAP1B CEP290 ANKRD26 GON4L FAM91A1 ODF2 XRCC4 CNTROB BRCA1 MYH14 RNF20	3.07e-05	645	153	12	25281560
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	CUL2 MYH9 DOCK10 CMYA5 PACS1 GTF2I RNF20 TRMT1L PLS1 VCL	3.36e-05	451	153	10	36168627
Pubmed	Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.	ERCC5 MSH3 XRCC4 MLH3 BRCA1	3.60e-05	84	153	5	19237606
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	SETD1A ASH2L KMT2C GTF2I	3.89e-05	43	153	4	33472061
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	PRUNE2 FAM91A1 MSH3 SLC1A3 WDR11 LNPEP SESN2 USP33	4.09e-05	285	153	8	34369648
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CHD9 CIC ASTN1 TMEM131 CTNND1	4.26e-05	87	153	5	12465718
Interaction	YWHAG interactions	DOCK4 SLK HIVEP2 CDC42BPA MAP2 MYO9A KIF1B BAG1 MCC ANKRD26 CNTLN CCDC6 MDM4 TTK CIC DNTTIP2 CCDC88C PACS1 NEK1 AKAP9 SIPA1L1 NAV2 ACIN1 BOD1L1 CGNL1 SSH2 CTNND1 AMOTL2 VCL	5.03e-08	1248	152	29	int:YWHAG
Interaction	YWHAQ interactions	CUL2 TPR MYH9 SLK HIVEP2 CDC42BPA MAP2 MYO9A KIF1B BAG1 ANKRD26 DAPK1 CCDC6 MDM4 CIC CCDC88C NEK1 BRCA1 SIPA1L1 RNF20 NAV2 CGNL1 SSH2 CTNND1 AMOTL2 GOLGB1 VCL	7.23e-08	1118	152	27	int:YWHAQ
Interaction	CEP135 interactions	CEP290 ANKRD26 CNTLN ODF2 TTK CNTROB CCDC88C AKAP9 SIPA1L1 TMEM131 CGNL1 CTNND1 GOLGB1	1.53e-07	272	152	13	int:CEP135
Interaction	YWHAB interactions	DOCK4 SLK CDC42BPA RASGRF1 MAP2 CENPE MYO9A KIF1B BAG1 MCC ANKRD26 DAPK1 CNTLN CCDC6 MDM4 CIC CCDC88C NEK1 AKAP9 SIPA1L1 NAV2 CGNL1 SSH2 CTNND1 AMOTL2	1.60e-07	1014	152	25	int:YWHAB
Interaction	YWHAE interactions	UBR2 HIVEP2 CDC42BPA IPO8 MAP1B RASGRF1 CENPE MYO9A KIF1B MCC ANKRD26 CNTLN CCDC6 MDM4 CIC CCDC88C PACS1 NEK1 AKAP9 BRCA1 SIPA1L1 NAV2 CGNL1 SSH2 CTNND1 AMOTL2 VCL	7.29e-07	1256	152	27	int:YWHAE
Interaction	NDC80 interactions	CENPE CEP290 ANKRD26 CNTLN ODF2 TTK CNTROB GTF2I AKAP9 MAP7D2 AMOTL2 PLS1 VCL	7.30e-07	312	152	13	int:NDC80
Interaction	YWHAH interactions	DOCK4 HIVEP2 CDC42BPA MAP2 MYO9A KIF1B CEP290 BAG1 ANKRD26 CCDC6 MDM4 TTK CIC CCDC88C PACS1 NEK1 AKAP9 SIPA1L1 NAV2 BOD1L1 CGNL1 SSH2 CTNND1 AMOTL2 VCL	7.54e-07	1102	152	25	int:YWHAH
Interaction	STX4 interactions	STX2 CDC42BPA ANK3 SYNE1 ANKRD26 FAM91A1 TTK STX1B STX1A NEO1 LNPEP TMEM131 CTNND1 GOLGB1 USP33	8.92e-07	428	152	15	int:STX4
Interaction	PCM1 interactions	CENPE MYO9A TRO KIF1B CEP290 ANKRD26 SMG5 CNTLN ODF2 SP110 TTK CNTROB KRT24 AKAP9 PDZRN3	1.06e-06	434	152	15	int:PCM1
Interaction	SEPTIN10 interactions	CDC42BPA ANKRD26 CNTROB AKAP9 PSME4 BRCA1 SIPA1L1 SEPTIN11 GOLGB1	1.49e-06	144	152	9	int:SEPTIN10
Interaction	USP7 interactions	TPR GPRASP1 MYH9 CDC42BPA CENPE TRO ZGRF1 SYNE1 UVSSA DOCK10 GON4L CNTLN CCDC6 XRCC4 MDM4 SP110 TTK CIC AXIN1 GTF2I CLCN5 BRCA1 SYCP1 NAV2 MAP7D2 CGNL1 GOLGB1	1.71e-06	1313	152	27	int:USP7
Interaction	YWHAZ interactions	CUL2 MYH9 SLK HIVEP2 CDC42BPA RASGRF1 MAP2 MYO9A KIF1B MCC ANKRD26 CCDC6 MDM4 SLC1A3 CIC CCDC88C PACS1 NEK1 KRT24 AKAP9 BRCA1 SIPA1L1 NAV2 CGNL1 SSH2 CTNND1 VCL	1.86e-06	1319	152	27	int:YWHAZ
Interaction	KCNA3 interactions	TPR MYH9 CDC42BPA ANK2 ANK3 MAP1B MYO9A KIF1B DOCK10 ANKRD26 CHD9 TTK AKAP12 CCDC88C KMT2C SIPA1L1 BOD1L1 RP1 CTNND1 GOLGB1 VCL	2.50e-06	871	152	21	int:KCNA3
Interaction	EBAG9 interactions	STX2 CDC42BPA ANK3 ANKRD26 FAM91A1 STX1A NEO1 WDR11 LNPEP CTNND1 GOLGB1 USP33	3.35e-06	303	152	12	int:EBAG9
Interaction	TRIM36 interactions	MAP2 KIF1B CEP290 TTK NEK1 EHBP1L1 BRCA1 MAP7D2	1.38e-05	144	152	8	int:TRIM36
Interaction	DYRK1A interactions	TPR ERCC5 DSCAM MAP1B LAMB1 TTK CIC SNED1 STX1A BRCA1 LNPEP SIPA1L1 SEPTIN11 CTNND1 GOLGB1	1.93e-05	552	152	15	int:DYRK1A
Interaction	SASS6 interactions	CENPE CEP290 ANKRD26 CCDC6 WASHC2A CNTROB SIPA1L1 CGNL1	2.82e-05	159	152	8	int:SASS6
Interaction	PFN1 interactions	DOCK4 TPR MYH9 ANK2 MYO9A ANKRD26 PATL1 CCDC6 NEK1 AKAP9 BRCA1 BOD1L1 GOLGB1 VCL	3.24e-05	509	152	14	int:PFN1
Interaction	H3C1 interactions	TPR SETD1A MYH9 ANK2 ANK3 KDM4C SYNE1 CEP290 INTS1 MSH3 CCDC6 ASH2L DNTTIP2 KMT2C CTCFL MYH14 NAV2 PWWP3B JHY	4.98e-05	901	152	19	int:H3C1
Interaction	GSK3A interactions	MAP2 MYO9A DRC1 CCDC6 WASHC2A CNTROB AXIN1 NEK1 AKAP9 SIPA1L1 ACIN1 CTNND1 VCL	5.19e-05	464	152	13	int:GSK3A
Interaction	ACTN1 interactions	MYH9 DSCAM MAP2 KIF1B DAPK1 XRCC4 CIC TOMM40 PLD2 GOLGB1 VCL	5.75e-05	341	152	11	int:ACTN1
Interaction	BRCA1 interactions	DOCK4 CUL2 TPR UBR2 SETD1A MYH9 ERCC5 KIF1B ANKRD26 CHD9 MSH3 CNTLN ODF2 ASH2L AKAP12 PARP4 CTCFL GTF2I BRCA1 MYH14 RNF20 PRPF39 VCL	6.26e-05	1249	152	23	int:BRCA1
Interaction	MAPRE3 interactions	DOCK4 MAP2 KIF1B PATL1 NEK1 AKAP9 NAV2 MAP7D2 TMEM131	6.41e-05	230	152	9	int:MAPRE3
Interaction	RHOB interactions	CUL2 UBR2 SLK CDC42BPA ANK3 MYO9A ANKRD26 FAM91A1 TTK SLC1A3 AKAP12 CCDC88C NEO1 LNPEP SIPA1L1 SEPTIN11 TOMM40 CTNND1	6.49e-05	840	152	18	int:RHOB
Interaction	TRIM52 interactions	CUL2 MYO9A CEP290 FAM91A1 WDR11 MAP7D2 PDZRN3	6.80e-05	133	152	7	int:TRIM52
Interaction	SFN interactions	SETD1A SLK CDC42BPA MAP1B MAP2 MYO9A KIF1B ANKRD26 MDM4 CCDC88C AKAP9 SIPA1L1 NAV2 CGNL1 SSH2 VCL	7.04e-05	692	152	16	int:SFN
Interaction	ACTC1 interactions	TPR MYH9 SYNE1 DAPK1 WASHC2A TTK ASH2L CIC GTF2I RNF20 SEPTIN11 ACIN1 BOD1L1 PLS1 GOLGB1 VCL	7.28e-05	694	152	16	int:ACTC1
Interaction	IMPDH2 interactions	CUL2 SLK MAP1B MYO9A BAG1 CCDC6 TTK ASH2L GTF2I AKAP9 BRCA1 RNF20	8.45e-05	420	152	12	int:IMPDH2
Interaction	GTF2IRD2 interactions	GTF2IRD2B GTF2I GTF2IRD2	8.80e-05	12	152	3	int:GTF2IRD2
Interaction	KCTD13 interactions	GPRASP1 MYH9 SLK ANK2 ANK3 MAP1B MAP2 MYO9A PPFIA4 SYNE1 KIF1B DAPK1 SLC1A3 STX1B PACS1 MYH14 SIPA1L1 VCAN SEPTIN11 MAP7D2 CGNL1 SSH2 CTNND1 VCL	1.21e-04	1394	152	24	int:KCTD13
Interaction	GBF1 interactions	TPR MYH9 SLK BAG1 FAM91A1 PATL1 TTK BRCA1 WDR11 SEPTIN11 CTNND1 VCL	1.36e-04	442	152	12	int:GBF1
Interaction	LZTS2 interactions	TPR MYH9 ANK3 MYO9A CEP290 SMG5 PATL1 ODF2 CCDC6 CNTROB WDCP SIPA1L1 CGNL1	1.39e-04	512	152	13	int:LZTS2
Interaction	MAPRE1 interactions	MAP1B MAP2 CENPE KIF1B CEP290 BAG1 ANKRD26 PATL1 AXIN1 AKAP9 NAV2 MAP7D2 TMEM131	1.45e-04	514	152	13	int:MAPRE1
Interaction	H2BC9 interactions	MYH9 MAP1B TRO CEP290 DAPK1 MSH3 ADGRG4 CCDC88C PARP4 MAP7D2 RP1 PRPF39	1.48e-04	446	152	12	int:H2BC9
Interaction	H2BC12 interactions	MYH9 MAP1B CENPE TRO BAG1 CIC CCDC88C PARP4 CLCN5 MAP7D2	1.71e-04	322	152	10	int:H2BC12
Interaction	RHOF interactions	CDC42BPA ANK3 ANKRD26 FAM91A1 MSH3 SLC1A3 BTN3A2 AKAP12 PACS1 EHBP1L1 WDR11 LNPEP SEPTIN11 TOMM40 GOLGB1	1.79e-04	673	152	15	int:RHOF
Interaction	GTF2IRD2B interactions	GTF2IRD2B GTF2I GTF2IRD2	1.79e-04	15	152	3	int:GTF2IRD2B
Interaction	NINL interactions	CENPE KIF1B CEP290 ANKRD26 CNTLN ODF2 TTK CCDC88C BRCA1 SIPA1L1 TMEM131 CGNL1	1.90e-04	458	152	12	int:NINL
Interaction	PPP1CA interactions	MYH9 SLK CENPE CCDC6 MDM4 SP110 CIC AXIN1 PRR16 PACS1 STX1A EHBP1L1 AKAP9 BRCA1 WDCP	2.56e-04	696	152	15	int:PPP1CA
Interaction	AARD interactions	STX2 STX1A KRT24	2.65e-04	17	152	3	int:AARD
Interaction	CCP110 interactions	CEP290 ODF2 CCDC6 WASHC2A CNTROB VCL USP33	2.70e-04	166	152	7	int:CCP110
Interaction	CEP85 interactions	SMG5 PATL1 ODF2 CCDC6 CNTROB WDCP VCL	3.01e-04	169	152	7	int:CEP85
Interaction	CFAP58 interactions	MCC ODF2 NAV2	3.16e-04	18	152	3	int:CFAP58
Interaction	DSCAM interactions	GPRASP1 DSCAM KDM4C SYNE1 SIPA1L1 ASTN1 AMOTL2	3.23e-04	171	152	7	int:DSCAM
Cytoband	7q11.23	GTF2IRD2B STX1A GTF2I GTF2IRD2	3.23e-04	97	153	4	7q11.23
Cytoband	6q23-q24	HIVEP2 TCF21	3.91e-04	9	153	2	6q23-q24
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MAP2 CMYA5 AKAP12 AKAP9	2.28e-05	29	105	4	396
GeneFamily	Syntaxins	STX2 STX1B STX1A	1.01e-04	16	105	3	818
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	PRUNE2 ATCAY	6.88e-04	7	105	2	1299
GeneFamily	Laminin subunits	LAMB1 LAMB3	2.12e-03	12	105	2	626
GeneFamily	Fibronectin type III domain containing	DSCAM CMYA5 SNED1 NEO1 ASTN1	2.42e-03	160	105	5	555
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK4 CUL2 UBR2 SLK HIVEP2 ZBTB20 CDC42BPA MAP1B CENPE KDM4C DAPK1 CHD9 MSH3 CCDC6 XRCC4 TTK NEK1 AKAP9 PSME4 BRCA1 SIPA1L1 TMEM131 VCL	1.07e-09	856	153	23	M4500
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CUL2 SLK ERCC5 CDC42BPA CENPE MYO9A CEP290 DOCK10 MSH3 XRCC4 TTK KIAA0319 NEK1 BRCA1 WDR11 RNF20 PRPF39 GOLGB1	5.93e-08	656	153	18	M18979
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	PRUNE2 MYH9 ANK2 MYO9A DOCK10 MCC LAMB3 DAPK1 MSH3 CNTLN TTK DNTTIP2 PACS1 PARP4 CLCN5 WDR11 MYH14 SIPA1L1 NAV2 CGNL1 SSH2 PDZRN3	1.06e-07	1009	153	22	M157
Coexpression	MURARO_PANCREAS_BETA_CELL	PRUNE2 GPRASP1 SLK HIVEP2 CDC42BPA MAP1B RASGRF1 MAP2 ABHD10 DOCK10 MCC CHD9 PATL1 KMT2C ABCG1 STX1A NEO1 MYH14 NAV2 PDZRN3 GOLGB1	1.58e-07	946	153	21	M39169
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	PRUNE2 MYH9 ANK2 DOCK10 MCC LAMB3 DAPK1 MSH3 PACS1 PARP4 WDR11 SIPA1L1 NAV2	1.91e-06	438	153	13	M227
Coexpression	HALLMARK_MITOTIC_SPINDLE	DOCK4 MYH9 CDC42BPA CENPE KIF1B TTK CNTROB SSH2 VCL	2.72e-06	199	153	9	M5893
Coexpression	ONDER_CDH1_TARGETS_2_UP	DOCK4 PRUNE2 MAP1B SYNE1 DOCK10 PRR16 SNED1 VCAN NAV2 SEPTIN11	2.90e-06	257	153	10	M13867
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PRUNE2 ZBTB20 ANK2 ANK3 ANKRD26 CHD9 SIPA1L1 CGNL1 GOLGB1	6.38e-06	221	153	9	M39222
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	UBR2 SLK HIVEP2 CDC42BPA MAP1B CENPE DAPK1 CHD9 XRCC4 AKAP9 BRCA1 TMEM131	1.99e-05	466	153	12	M13522
Coexpression	GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP	STX2 UBR2 ERCC5 DOCK10 DRC1 CCDC88C IRF9 SSH2	2.32e-05	199	153	8	M3050
Coexpression	GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	TPR HIVEP2 DOCK10 SP110 KMT2C EHBP1L1 SIPA1L1 TRMT1L	2.40e-05	200	153	8	M3510
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	DOCK4 ZBTB20 ANK3 DSCAM MAP1B SYNE1 ABHD10 KIF1B SMG5 SLC1A3 SLC41A2 SLC17A5 SNED1 NEO1 BRCA1 NAV2 ASTN1 AMOTL2 PLS1	2.42e-05	1102	153	19	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	DOCK4 ZBTB20 ANK3 DSCAM MAP1B SYNE1 ABHD10 KIF1B SMG5 SLC1A3 SLC41A2 SLC17A5 SNED1 NEO1 BRCA1 NAV2 ASTN1 AMOTL2 PLS1	3.17e-05	1124	153	19	MM1070
Coexpression	GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN	DAPK1 TTK ADGRL4 SNED1 PACS1 SIPA1L1 RNF20	3.35e-05	153	153	7	M8815
Coexpression	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	ANK2 CENPE ODF2 DNTTIP2 STX1A CLCN5 BRCA1	5.21e-05	164	153	7	M19957
Coexpression	MATZUK_SPERMATOCYTE	STX2 UBR2 MLH3 SYCP1 SMC1B	6.48e-05	72	153	5	M1831
Coexpression	MATZUK_SPERMATOCYTE	STX2 UBR2 MLH3 SYCP1 SMC1B	6.92e-05	73	153	5	MM1234
Coexpression	GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	HIVEP2 MSH3 AKAP9 WDR11 SIPA1L1 CTNND1 USP33	7.56e-05	174	153	7	M6881
Coexpression	MATZUK_MEIOTIC_AND_DNA_REPAIR	UBR2 MLH3 SYCP1 SMC1B	7.83e-05	39	153	4	M1819
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	GPRASP1 HIVEP2 ZBTB20 MYO9A UVSSA GON4L CHD9 MDM4 SNED1 ABCG1 NEO1 AKAP9 WDR11 CTNND1 GOLGB1	8.04e-05	807	153	15	M16651
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	PRUNE2 ZBTB20 ANK3 ANKRD26 AKAP12 SIPA1L1 SSH2	8.12e-05	176	153	7	M39223
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	DOCK4 MYH9 CDC42BPA SYNE1 AKAP12 PRR16 AKAP9	8.42e-05	177	153	7	M39245
Coexpression	GCNP_SHH_UP_LATE.V1_DN	STX2 PPFIA4 AXIN1 IRF9 STX1A PLD2 AMOTL2	8.72e-05	178	153	7	M2640
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	DMTF1 UBR2 SLK HIVEP2 MYO9A GON4L AXIN1 SLC17A5 IRF9 STX1A CSF2 AKAP9 GMEB1 NAV2 GOLGB1	9.85e-05	822	153	15	M6782
Coexpression	AIZARANI_LIVER_C33_STELLATE_CELLS_2	MYH9 CDC42BPA ANK3 MAP1B LAMB1 SEPTIN11	9.92e-05	126	153	6	M39132
Coexpression	LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB	ANK2 MYO9A ANKRD26 LAMB1 CLCN5 CGNL1	1.23e-04	131	153	6	M39232
Coexpression	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	DMTF1 EXO5 ZBTB20 KIF1B AKAP12 PARP4 GTF2I SIPA1L1 PLS1 JHY	1.46e-04	407	153	10	M2214
Coexpression	CUI_TCF21_TARGETS_2_DN	DOCK4 SLK HIVEP2 TCF21 KDM4C KIF1B MCC SLFN5 ADGRL4 SLC17A5 KMT2C PARP4 LNPEP VCL USP33	1.50e-04	854	153	15	M1533
Coexpression	LIU_PROSTATE_CANCER_DN	GPRASP1 CPAMD8 ANK2 MAP1B TRO LAMB1 LAMB3 SLFN5 AKAP12 NAV2 VCL	1.58e-04	493	153	11	M19391
Coexpression	SENESE_HDAC3_TARGETS_UP	DOCK4 TPR HIVEP2 ZBTB20 MAP2 SLFN5 STX1A GTF2I PSME4 CLCN5 SEPTIN11	1.64e-04	495	153	11	M8451
Coexpression	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	GPRASP1 KIF1B DOCK10 SMG5 CAPN11 SNED1 KMT2C	1.69e-04	198	153	7	M8624
Coexpression	GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP	TCF21 MAP1B CEP290 SMG5 PARP4 GTF2I PDZRN3	1.74e-04	199	153	7	M3857
Coexpression	GSE30083_SP2_VS_SP3_THYMOCYTE_UP	ANK2 CARMIL3 ATCAY CMYA5 PRR16 CSF2 JHY	1.74e-04	199	153	7	M5031
Coexpression	GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN	GPRASP1 ZBTB20 SLFN5 KMT2C ABCG1 AKAP9 SSH2	1.74e-04	199	153	7	M9253
Coexpression	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	MYH9 BOD1L1 AMOTL2 VCL	1.78e-04	48	153	4	M10253
Coexpression	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	MYH9 BOD1L1 AMOTL2 VCL	1.78e-04	48	153	4	MM1088
Coexpression	GSE14308_INDUCED_VS_NATURAL_TREG_DN	SLK HIVEP2 CNTLN KIAA0319 CCDC88C STX1A TRMT1L	1.80e-04	200	153	7	M3399
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP	STX2 ABHD10 CNTLN AKAP12 IRF9 BRCA1 VCAN	1.80e-04	200	153	7	M3838
Coexpression	GSE3039_CD4_TCELL_VS_NKT_CELL_UP	DOCK4 MYO9A SYNE1 IRF9 SSH2 RAB37 VCL	1.80e-04	200	153	7	M6426
Coexpression	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN	MYH9 SYNE1 DAPK1 ODF2 ABCG1 ASTN1 VCL	1.80e-04	200	153	7	M5216
Coexpression	GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN	DOCK4 ZBTB20 DRC1 CHD9 CCDC88C TMEM131 SSH2	1.80e-04	200	153	7	M5705
Coexpression	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	UBR2 ANK2 KDM4C KIF1B DAPK1 ABCG1 MLH3 CLCN5 PDZRN3	1.82e-04	340	153	9	M2012
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	MYH9 HIVEP2 CDC42BPA ANK3 MAP2 LAMB1 CMYA5 SLC17A5 PACS1 ABCG1 SESN2	1.91e-04	504	153	11	M2157
Coexpression	PECE_MAMMARY_STEM_CELL_DN	STX2 GPRASP1 UVSSA SLC41A2 SNED1 VCAN	2.06e-04	144	153	6	M2535
Coexpression	MENON_FETAL_KIDNEY_4_PODOCYTES	MYH9 SLK TCF21 CMYA5 SEPTIN11 CGNL1 GOLGB1	2.15e-04	206	153	7	M39254
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	UBR2 ERCC5 INTS1 BAG1 PARP4 GTF2I BRCA1 VCAN	2.27e-04	276	153	8	M3063
Coexpression	CUI_TCF21_TARGETS_2_DN	DOCK4 SLK HIVEP2 TCF21 KDM4C KIF1B MCC SLFN5 ADGRL4 SLC17A5 KMT2C PARP4 LNPEP VCL USP33	2.28e-04	888	153	15	MM1018
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	DOCK4 MYH9 SLK HIVEP2 KIF1B CMYA5 SEPTIN11	2.56e-04	212	153	7	M39221
Coexpression	GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP	CUL2 TRO ABHD10 CNTLN MDM4 CSF2	2.86e-04	153	153	6	M438
Coexpression	DER_IFN_BETA_RESPONSE_UP	MAP1B BAG1 SP110 IRF9 PARP4	3.51e-04	103	153	5	M13453
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	SLK ZBTB20 CENPE TRO ZGRF1 CEP290 CHD9 CNTLN ODF2 STX1B NEK1 AKAP9 RNF20 ASTN1 BOD1L1 TMEM131 GOLGB1 MAP3K19	5.62e-07	629	151	18	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	TPR MYH9 IPO8 ANK3 MAP1B KIF1B NEK1 STX1A GTF2I AKAP9 LNPEP WDCP VCAN PRPF39	6.84e-07	385	151	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500	MYH9 ANK3 LAMB1 MSH3 NEK1 STX1A AKAP9 LNPEP PRPF39	1.79e-06	156	151	9	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500	ZBTB20 ANK3 MAP1B RASGRF1 LAMB1 MSH3 AKAP9 LNPEP WDCP PRPF39	1.82e-06	201	151	10	gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	SMIM24 TPR SLK ZBTB20 MAP2 CENPE TRO SYNE1 CEP290 C11orf24 SMG5 CNTLN ODF2 AKAP9 MYH14 ASTN1 BOD1L1 TMEM131 PLS1 GOLGB1 JHY MAP3K19	2.00e-06	989	151	22	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	MYH9 ANK3 LAMB1 GON4L MSH3 STX1A AKAP9 LNPEP WDCP VCAN PRPF39	2.76e-06	261	151	11	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	MAP1B CENPE CEP290 ANKRD26 PATL1 ODF2 XRCC4 TTK DNTTIP2 BRCA1 MAP7D2 ACIN1 TRMT1L PRPF39 JHY	6.25e-06	532	151	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	ZBTB20 MAP1B CENPE CEP290 ODF2 TTK AKAP9 BRCA1 MAP7D2 ASTN1	6.52e-06	232	151	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	ZBTB20 CDC42BPA ANK2 MAP1B MAP2 CENPE CARMIL3 ATCAY CEP290 ANKRD26 CNTLN ODF2 TTK STX1B DNTTIP2 CCDC88C AKAP9 BRCA1 MAP7D2 ASTN1 PRPF39	6.55e-06	983	151	21	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	TPR CENPE CEP290 ANKRD26 ODF2 AKAP9 MAP7D2 BOD1L1 PRPF39	7.58e-06	186	151	9	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	TPR GCFC2 ERCC5 IPO8 ANK2 CENPE ZGRF1 CEP290 ANKRD26 CHD9 CNTLN ODF2 TTK DNTTIP2 CCDC88C AKAP9 PSME4 BRCA1 MYH14 RNF20 ASTN1 BOD1L1 PWWP3B PRPF39	9.04e-06	1257	151	24	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ZBTB20 CENPE CEP290 ANKRD26 ODF2 AKAP9 BRCA1 MAP7D2 MAP3K19	9.79e-06	192	151	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	PRUNE2 MYH9 ZBTB20 TCF21 MAP1B SYNE1 KIF1B MSH3 AKAP12 NEK1 STX1A NEO1 EHBP1L1 AKAP9 LNPEP VCAN PRPF39 VCL	9.88e-06	772	151	18	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	ZBTB20 MAP1B MAP2 CENPE CARMIL3 ATCAY CEP290 ODF2 TTK CCDC88C AKAP9 BRCA1 MAP7D2 ASTN1	1.19e-05	493	151	14	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	TPR GCFC2 ERCC5 IPO8 ANK2 MAP1B MAP2 CENPE ZGRF1 CEP290 ANKRD26 CHD9 CNTLN ODF2 TTK DNTTIP2 CCDC88C AKAP9 PSME4 BRCA1 MYH14 RNF20 ASTN1 BOD1L1 PWWP3B PRPF39	1.24e-05	1459	151	26	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	TPR GCFC2 ZBTB20 CDC42BPA IPO8 ANK2 MAP1B MAP2 CENPE KIF1B CEP290 ANKRD26 CHD9 C11orf24 ODF2 CCDC88C AKAP9 PSME4 BRCA1 MYH14 RNF20 ASTN1 BOD1L1 PWWP3B AMOTL2	1.25e-05	1370	151	25	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	ZBTB20 MAP1B MAP2 CENPE ATCAY CEP290 ANKRD26 ODF2 CCDC88C AKAP9 BRCA1 MAP7D2 JHY MAP3K19	1.33e-05	498	151	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	TPR MYH9 ANK3 MAP1B KIF1B MSH3 GTF2I LNPEP WDCP VCAN PRPF39	1.50e-05	312	151	11	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	TPR GCFC2 IPO8 ANK2 MAP1B MAP2 CENPE CEP290 ANKRD26 LAMB3 CHD9 CNTLN ODF2 SLC1A3 STX1B ADGRL4 CCDC88C AKAP9 PSME4 BRCA1 MYH14 WDCP ASTN1 BOD1L1 RAB37	2.13e-05	1414	151	25	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	TPR MYH9 IPO8 ANK2 ANK3 MAP1B KIF1B LAMB1 NEK1 STX1A GTF2I AKAP9 LNPEP WDCP SIPA1L1 VCAN ASTN1 PRPF39	2.14e-05	818	151	18	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	MAP1B MAP2 KIF1B MSH3 NEK1 GTF2I AKAP9 LNPEP WDCP VCAN PRPF39	2.51e-05	330	151	11	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	GCFC2 ZBTB20 MAP1B CENPE MYO9A ABHD10 CEP290 ANKRD26 GON4L MSH3 ODF2 NEK1 AKAP9 BRCA1 MAP7D2 ASTN1 BOD1L1 MAP3K19	2.64e-05	831	151	18	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	MYH9 ANK3 CENPE LAMB1 MSH3 NEK1 STX1A AKAP9 LNPEP WDCP PRPF39	3.21e-05	339	151	11	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500	SMIM24 ZBTB20 MAP2 CENPE SYNE1 CEP290 CNTLN ODF2 AKAP9 MYH14 ASTN1 PLS1 MAP3K19	5.19e-05	492	151	13	Facebase_RNAseq_e10.5_Maxillary Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	TPR SLK CENPE TRO SYNE1 CEP290 CNTLN ODF2 BOD1L1 TMEM131 GOLGB1 MAP3K19	6.33e-05	432	151	12	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	TPR GCFC2 IPO8 ANK2 MAP1B CENPE CEP290 ANKRD26 CHD9 CNTLN ODF2 STX1B CCDC88C AKAP9 PSME4 BRCA1 MYH14 WDCP ASTN1 BOD1L1	6.44e-05	1060	151	20	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	TPR CENPE CEP290 DOCK10 ANKRD26 ODF2 SP110 STX1B PRR16 SNED1 CTCFL AKAP9 MYH14 MAP7D2 ASTN1 BOD1L1 PWWP3B PRPF39 MAP3K19	6.78e-05	978	151	19	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	TPR ANK3 CENPE CEP290 ANKRD26 CHD9 MSH3 CNTLN ODF2 SP110 TTK CNTROB DNTTIP2 PRR16 SNED1 AKAP9 BRCA1 MYH14 VCAN BOD1L1 PWWP3B PRPF39	6.79e-05	1241	151	22	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	TPR IPO8 ANK3 MAP1B KIF1B MSH3 AKAP9 LNPEP WDCP VCAN PRPF39	6.90e-05	369	151	11	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	CENPE CEP290 ANKRD26 C11orf24 TTK AKAP9 BRCA1 ASTN1	7.12e-05	192	151	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	TPR ZBTB20 MAP1B MAP2 CENPE CARMIL3 ATCAY KIF1B CEP290 CNTLN ODF2 SLC1A3 CCDC88C AKAP9 BRCA1 MAP7D2 ASTN1 PDZRN3 JHY	7.55e-05	986	151	19	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	ZBTB20 CENPE CEP290 ANKRD26 ODF2 NEK1 AKAP9 BRCA1 BOD1L1 MAP3K19	7.98e-05	311	151	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3	TPR CENPE SYNE1 UVSSA CEP290 DOCK10 ANKRD26 CNTLN ODF2 SP110 PRR16 SNED1 BOD1L1 PWWP3B PRPF39 PDZRN3 MAP3K19	9.44e-05	834	151	17	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_100	SYCP1 MAP7D2 SMC1B	9.57e-05	13	151	3	gudmap_dev gonad_e13.5_M_GermCell_Oct_k3_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	TPR MYH9 ANK3 MAP1B LNPEP WDCP VCAN	9.66e-05	149	151	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500	ANK3 MAP1B STX1A GTF2I LNPEP WDCP VCAN PRPF39	1.28e-04	209	151	8	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	UBR2 EXO5 GCFC2 CENPE MYO9A ABHD10 CEP290 BAG1 ANKRD26 GON4L C11orf24 MSH3 TTK AKAP9 BRCA1 ASTN1	1.43e-04	780	151	16	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	CENPE CEP290 ANKRD26 ODF2 STX1B AKAP9 MAP7D2 ASTN1 PRPF39	1.43e-04	271	151	9	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	TPR MYH9 ANK3 MAP1B KIF1B LAMB3 MSH3 PRR16 GTF2I LNPEP WDCP SIPA1L1 VCAN ASTN1 PRPF39 VCL	2.07e-04	806	151	16	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	SMIM24 TPR ZBTB20 CENPE ATCAY CEP290 DOCK10 SLFN5 CNTLN TTK SLC1A3 SLC41A2 IRF9 MYH14 CGNL1 PLS1 GOLGB1 JHY	2.11e-04	979	151	18	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	DOCK4 SETD1A MYO9A KIF1B ANKRD26 CHD9 GMEB1 NAV2	2.13e-04	225	151	8	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	TPR CENPE CEP290 DOCK10 ANKRD26 ODF2 AKAP9 MAP7D2 BOD1L1 PWWP3B PRPF39 MAP3K19	2.14e-04	492	151	12	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500	ZBTB20 ANK3 LNPEP WDCP VCAN	2.37e-04	78	151	5	gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ZBTB20 MAP1B MAP2 CENPE ATCAY CEP290 ANKRD26 ODF2 CCDC88C NEK1 AKAP9 BRCA1 NAV2 MAP7D2 ASTN1 BOD1L1 JHY MAP3K19	2.39e-04	989	151	18	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000	TPR MYH9 ANK3 STX1A AKAP9 LNPEP PRPF39	2.43e-04	173	151	7	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	ZBTB20 CDC42BPA MAP1B CENPE CEP290 ANKRD26 ODF2 STX1B DNTTIP2 AKAP9 BRCA1 MAP7D2 ASTN1 PRPF39	2.45e-04	654	151	14	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	ZBTB20 MAP1B CEP290 ODF2 CCDC88C AKAP9 BRCA1 MAP7D2 ASTN1	2.90e-04	298	151	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_1000	MYH9 HIVEP2 ZBTB20 CDC42BPA LNPEP SEPTIN11	2.98e-04	127	151	6	gudmap_kidney_adult_Mesangium_Meis_k1_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500	MYO9A ZGRF1 NEK1 SYCP1 MAP7D2 SMC1B	3.25e-04	129	151	6	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500
CoexpressionAtlas	kidney_adult_Podocyte_MafB_top-relative-expression-ranked_500	DOCK4 HIVEP2 ZBTB20 TCF21 MCC SLC41A2 NEK1 PARP4 LNPEP SEPTIN11 CGNL1	3.51e-04	445	151	11	gudmap_kidney_adult_Podocyte_MafB_500
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000	MYH9 ZBTB20 ANK3 LAMB1 MSH3 GTF2I AKAP9 LNPEP WDCP PRPF39	3.62e-04	375	151	10	gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000	MYO9A STX1B KMT2C NEK1 SYCP1 SSH2 SMC1B	3.90e-04	187	151	7	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500	DOCK4 CEP290 KMT2C SYCP1 MAP7D2 SMC1B	3.98e-04	134	151	6	gudmap_developingGonad_e18.5_ovary_500_k1
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	DOCK4 SETD1A MYO9A KIF1B CEP290 ANKRD26 CHD9 KMT2C BRCA1 SYCP1 GMEB1 NAV2 MAP7D2 ACIN1 SMC1B	4.35e-04	776	151	15	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	DOCK4 MAP2 MYO9A DAPK1 SLC41A2 NEO1 NAV2	4.43e-04	191	151	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	MAP1B CENPE CCDC88C AKAP9 MAP7D2 ASTN1	4.83e-04	139	151	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500	PRUNE2 MYH9 MAP1B SYNE1 KIF1B EHBP1L1 AKAP9 LNPEP VCAN PRPF39	5.22e-04	393	151	10	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	CENPE CEP290 XRCC4 TTK DNTTIP2 AKAP9 MYH14 TMEM131 TRMT1L CTNND1 JHY	5.45e-04	469	151	11	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	MYH9 ZBTB20 ANK3 MAP1B RASGRF1 MROH2A KIF1B LAMB1 MSH3 STX1A GTF2I AKAP9 LNPEP WDCP PRPF39	5.58e-04	795	151	15	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500	MYH9 KIF1B AKAP9 LNPEP PRPF39	5.62e-04	94	151	5	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	TPR MAP2 CENPE CEP290 ANKRD26 CHD9 CNTLN ODF2 SP110 TTK AKAP9 PSME4 MYH14 WDCP VCAN BOD1L1 TMEM131 PWWP3B PRPF39 PDZRN3	5.77e-04	1252	151	20	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	ZBTB20 CDC42BPA MAP1B STX1B DNTTIP2 AKAP9 BRCA1 MAP7D2 ASTN1	5.81e-04	328	151	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200	LAMB1 AKAP9 LNPEP PRPF39	5.90e-04	54	151	4	gudmap_developingKidney_e15.5_cortic collect duct_200_k3
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500	ZBTB20 ANK3 MAP1B RASGRF1 LAMB1 MSH3 AKAP9 LNPEP WDCP PRPF39	6.21e-04	402	151	10	gudmap_developingKidney_e15.5_anlage of loop of Henle_500
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000	ZBTB20 ANK3 LNPEP WDCP VCAN PRPF39	6.27e-04	146	151	6	gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000	MYH9 KIF1B MSH3 NEK1 AKAP9 LNPEP PRPF39	6.36e-04	203	151	7	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500	MYH9 ANK3 LAMB1 MSH3 NEK1 STX1A AKAP9 LNPEP MAP7D2 PRPF39	6.71e-04	406	151	10	gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	TPR ANK3 CENPE CEP290 ANKRD26 CHD9 MSH3 CNTLN ODF2 SP110 TTK CNTROB DNTTIP2 PRR16 SNED1 AKAP9 BRCA1 MYH14 VCAN BOD1L1 PWWP3B PRPF39	7.11e-04	1468	151	22	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000	SETD1A ZBTB20 CENPE LAMB1 GMEB1 NAV2	7.48e-04	151	151	6	gudmap_developingGonad_P2_ovary_1000_k5
CoexpressionAtlas	dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000	HIVEP2 ZBTB20 ANK2 MAP1B MAP2 KIF1B AKAP12 NEK1	8.64e-04	278	151	8	gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000
CoexpressionAtlas	kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000	DOCK4 MYH9 HIVEP2 ZBTB20 TCF21 KDM4C SYNE1 MCC SLC41A2 SLC17A5 NEK1 PARP4 LNPEP SEPTIN11 CGNL1	9.54e-04	838	151	15	gudmap_kidney_adult_Podocyte_MafB_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000	DOCK4 MYO9A CEP290 SLC41A2 KMT2C SYCP1 SMC1B	9.93e-04	219	151	7	gudmap_developingGonad_e16.5_ovary_1000_k5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500	SETD1A CENPE ANKRD26 CHD9 GMEB1 NAV2	1.04e-03	161	151	6	gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	DMTF1 SLK MAP1B TRO ZGRF1 CHD9 NEK1 SIPA1L1 RNF20 MAP7D2 BOD1L1 GOLGB1	1.15e-03	595	151	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500	MAP1B MSH3 LNPEP WDCP VCAN PRPF39	1.18e-03	165	151	6	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000	DOCK4 CEP290 SLC41A2 KMT2C SYCP1 MAP7D2 SMC1B	1.32e-03	230	151	7	gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	TPR CENPE CEP290 DOCK10 CNTLN TTK MYH14 GOLGB1	1.35e-03	298	151	8	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_200	SYCP1 MAP7D2 SMC1B	1.37e-03	31	151	3	gudmap_developingGonad_e14.5_ ovary_200_k3
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	DOCK4 MAP2 MYO9A DAPK1 CNTLN SLC41A2 NEO1 NAV2	1.44e-03	301	151	8	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500	MYO9A SYCP1 MAP7D2 SMC1B	1.48e-03	69	151	4	gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200	MAP1B LNPEP VCAN PRPF39	1.48e-03	69	151	4	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500	MYH9 ANK3 LAMB1 AKAP9 PRPF39	1.50e-03	117	151	5	gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	MYH9 ANK3 LAMB1 MSH3 GTF2I AKAP9 LNPEP WDCP PRPF39	1.60e-03	379	151	9	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000	IPO8 TRO KIF1B DOCK10 CNTLN AKAP12 SNED1 CGNL1	1.63e-03	307	151	8	gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	DOCK4 SETD1A ZBTB20 MYO9A CEP290 CHD9 SLC41A2 KMT2C SYCP1 GMEB1 NAV2 MAP7D2 ACIN1 SMC1B	1.64e-03	795	151	14	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100	MAP1B LNPEP VCAN	1.64e-03	33	151	3	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR UBR2 SLFN5 MDM4 SP110 IRF9 KMT2C AKAP9 ACIN1 BOD1L1 GOLGB1	1.09e-10	200	153	11	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPAMD8 ANK2 SYNE1 LAMB1 ABCA10 AKAP12 PRR16 SNED1 VCAN NAV2 PDZRN3	1.09e-10	200	153	11	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	ZBTB20 ANK2 MAP1B MAP2 ATCAY CHD9 GTF2I AKAP9 VCAN SEPTIN11	1.80e-09	198	153	10	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	TPR ANKRD26 SLFN5 DNTTIP2 AKAP12 GTF2I AKAP9 BOD1L1 GOLGB1 VCL	1.89e-09	199	153	10	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 SYNE1 LAMB1 ABCA10 AKAP12 PRR16 SNED1 VCAN NAV2 PDZRN3	1.99e-09	200	153	10	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TCF21 SYNE1 LAMB1 ABCA10 ADGRG4 AKAP12 PRR16 VCAN NAV2 PDZRN3	1.99e-09	200	153	10	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK4 CPAMD8 ANK2 SYNE1 LAMB1 SLC1A3 AKAP12 VCAN SEPTIN11 PDZRN3	1.99e-09	200	153	10	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZBTB20 TCF21 LAMB1 SLC1A3 AKAP12 SNED1 NEO1 VCAN NAV2	2.28e-08	192	153	9	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZBTB20 TCF21 LAMB1 SLC1A3 AKAP12 SNED1 NEO1 VCAN NAV2	2.28e-08	192	153	9	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK3 MYO9A CEP290 LAMB3 DAPK1 AKAP9 MYH14 CGNL1 GOLGB1	2.85e-08	197	153	9	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ANK2 LAMB1 ABCA10 PRR16 SNED1 VCAN NAV2 SEPTIN11 PDZRN3	2.98e-08	198	153	9	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DMTF1 UBR2 ZBTB20 ANK3 SYNE1 MDM4 IRF9 AKAP9 GOLGB1	3.11e-08	199	153	9	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TPR CDC42BPA MAP1B CEP290 SLFN5 AKAP9 SEPTIN11 BOD1L1 GOLGB1	3.11e-08	199	153	9	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DOCK4 ANK2 SYNE1 LAMB1 SLC1A3 AKAP12 VCAN SEPTIN11 PDZRN3	3.11e-08	199	153	9	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DOCK4 ANK2 SYNE1 LAMB1 SLC1A3 AKAP12 AKAP9 VCAN PDZRN3	3.25e-08	200	153	9	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 CPAMD8 ANK2 SYNE1 LAMB1 PRR16 SNED1 VCAN NAV2	3.25e-08	200	153	9	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 SYNE1 LAMB1 ABCA10 AKAP12 PRR16 SNED1 VCAN NAV2	3.25e-08	200	153	9	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TCF21 MAP1B SYNE1 LAMB1 ABCA10 PRR16 VCAN NAV2 PDZRN3	3.25e-08	200	153	9	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR GPRASP1 ZBTB20 MYO9A CHD9 CMYA5 PSME4 LNPEP	1.78e-07	176	153	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR PPFIA4 DOCK10 CHD9 SLFN5 AKAP12 LNPEP SEPTIN11	2.51e-07	184	153	8	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK4 TCF21 LAMB1 AKAP12 NEO1 VCAN NAV2 VCL	3.07e-07	189	153	8	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB20 CDC42BPA ANK3 MYO9A SYNE1 LAMB1 DAPK1 RP1	3.07e-07	189	153	8	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK4 TCF21 LAMB1 AKAP12 NEO1 VCAN NAV2 VCL	3.20e-07	190	153	8	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	DOCK4 ZBTB20 TCF21 UVSSA DOCK10 DAPK1 PRR16 SNED1	3.20e-07	190	153	8	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF21 ANK2 LAMB1 SLC1A3 PRR16 SNED1 VCAN PDZRN3	3.33e-07	191	153	8	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ZBTB20 LAMB1 CHD9 ABCA10 PRR16 SNED1 VCAN SSH2	3.33e-07	191	153	8	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 MYO9A SYNE1 DAPK1 SLC41A2 MYH14 RP1 SSH2	3.61e-07	193	153	8	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 MYO9A SYNE1 DAPK1 SLC41A2 MYH14 RP1 SSH2	3.61e-07	193	153	8	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK4 TCF21 LAMB1 SLC1A3 PRR16 SNED1 VCAN PDZRN3	3.75e-07	194	153	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRUNE2 TPR ZBTB20 MAP1B CMYA5 AKAP12 AKAP9 GOLGB1	3.75e-07	194	153	8	8985095f291c1b54e45f4edece49aa26e8c8b732
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF21 ANK2 SYNE1 LAMB1 SLC1A3 PRR16 SNED1 PDZRN3	3.75e-07	194	153	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZBTB20 TCF21 LAMB1 SLC1A3 AKAP12 SNED1 NEO1 NAV2	3.90e-07	195	153	8	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZBTB20 TCF21 LAMB1 SLC1A3 AKAP12 SNED1 NEO1 NAV2	3.90e-07	195	153	8	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B CARMIL3 KIF1B KMT2C AKAP9 NAV2 BOD1L1 GOLGB1	3.90e-07	195	153	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B CARMIL3 KIF1B KMT2C AKAP9 NAV2 BOD1L1 GOLGB1	3.90e-07	195	153	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 TCF21 SYNE1 ABCA10 ADGRG4 AKAP12 NAV2 PDZRN3	4.21e-07	197	153	8	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	MAP1B CENPE CEP290 ANKRD26 CNTLN AKAP9 BOD1L1 GOLGB1	4.21e-07	197	153	8	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CDC42BPA CEP290 ANKRD26 SLFN5 DNTTIP2 AKAP9 BOD1L1 GOLGB1	4.38e-07	198	153	8	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 MUC16 DRC1 AKAP9 MYH14 RP1 GOLGB1 MAP3K19	4.38e-07	198	153	8	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TCF21 LAMB1 AKAP12 PRR16 SNED1 VCAN SEPTIN11 PDZRN3	4.38e-07	198	153	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	STX2 CDC42BPA CEP290 ANKRD26 SLFN5 AKAP9 BOD1L1 GOLGB1	4.55e-07	199	153	8	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TPR CDC42BPA CEP290 ANKRD26 SLFN5 AKAP9 BOD1L1 GOLGB1	4.55e-07	199	153	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANK2 SYNE1 LAMB1 SLC1A3 AKAP12 VCAN SEPTIN11 PDZRN3	4.55e-07	199	153	8	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK4 SYNE1 LAMB1 SLC1A3 AKAP12 VCAN SEPTIN11 PDZRN3	4.72e-07	200	153	8	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO9A CEP290 LAMB3 DAPK1 MYH14 NAV2 CGNL1 GOLGB1	4.72e-07	200	153	8	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 MAP1B LAMB1 ABCA10 AKAP12 PRR16 VCAN PDZRN3	4.72e-07	200	153	8	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK4 TCF21 LAMB1 ABCA10 AKAP12 PRR16 NAV2 PDZRN3	4.72e-07	200	153	8	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANK2 SYNE1 LAMB1 SLC1A3 AKAP12 VCAN SEPTIN11 PDZRN3	4.72e-07	200	153	8	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 LAMB1 ABCA10 AKAP12 PRR16 VCAN NAV2 PDZRN3	4.72e-07	200	153	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK4 SYNE1 LAMB1 SLC1A3 AKAP12 VCAN SEPTIN11 PDZRN3	4.72e-07	200	153	8	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANK2 SYNE1 LAMB1 SLC1A3 AKAP12 VCAN SEPTIN11 PDZRN3	4.72e-07	200	153	8	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 MAP2 MYO9A PPFIA4 MYH14 C2 PLD2	2.24e-06	172	153	7	7fb31ccbcd0204c3612986a6bc20d57ed6825e9c
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 MAP2 MYO9A PPFIA4 MYH14 C2 PLD2	2.24e-06	172	153	7	2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLK ANK3 MUC16 CMYA5 MYH14 CTNND1 GOLGB1	2.92e-06	179	153	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ANK2 ANK3 CMYA5 CHRM2 SLC1A3 PDZRN3 VCL	3.50e-06	184	153	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH9 AKAP12 SNED1 VCAN NAV2 VCL SMC1B	3.62e-06	185	153	7	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ANK2 ANK3 CMYA5 CHRM2 SLC1A3 PDZRN3 VCL	3.62e-06	185	153	7	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ZBTB20 MYO9A SYNE1 LAMB1 SEPTIN11 RP1	3.76e-06	186	153	7	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF21 ANK2 LAMB1 SLC1A3 PRR16 SNED1 PDZRN3	4.17e-06	189	153	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	facs-Pancreas-Endocrine-24m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ANK2 MAP1B ABCG1 NAV2 ASTN1 RAB37	4.17e-06	189	153	7	010fdd70e9d0e21b856306a29ff877776a480319
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH9 ZBTB20 MAP1B AKAP9 SEPTIN11 CGNL1 GOLGB1	4.32e-06	190	153	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ZBTB20 LAMB1 CHD9 ABCA10 PRR16 SNED1 SSH2	4.32e-06	190	153	7	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ANK2 LAMB1 ABCA10 AKAP12 PRR16 VCAN PDZRN3	4.32e-06	190	153	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DOCK4 TCF21 SLC1A3 AKAP12 NEO1 VCAN SEPTIN11	4.47e-06	191	153	7	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ANK2 MAP1B RASGRF1 NAV2 ASTN1 GOLGB1	4.47e-06	191	153	7	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	CPAMD8 ANK3 DSCAM DAPK1 MYH14 NAV2 CGNL1	4.47e-06	191	153	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ANK2 MAP1B ABCG1 NAV2 ASTN1 RAB37	4.47e-06	191	153	7	a251b134f67a0a1ef3a42f50042f128a17f20b22
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PRUNE2 CDC42BPA MAP2 MUC16 CMYA5 AMOTL2 PLS1	4.63e-06	192	153	7	8899d81306770adda893b5e146df1253971754c5
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PRUNE2 CDC42BPA MAP2 MUC16 CMYA5 AMOTL2 PLS1	4.63e-06	192	153	7	5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF21 ANK2 LAMB1 SLC1A3 PRR16 SNED1 PDZRN3	4.63e-06	192	153	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOCK4 ZBTB20 KDM4C DAPK1 KMT2C SIPA1L1 SSH2	4.79e-06	193	153	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ZBTB20 MYO9A LAMB1 AKAP12 PARP4 SEPTIN11	4.79e-06	193	153	7	ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF21 ANK2 LAMB1 SLC1A3 PRR16 SNED1 PDZRN3	4.79e-06	193	153	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LA\|World / Chamber and Cluster_Paper	PRUNE2 MAP1B ABCA10 SLC41A2 VCAN NAV2 SEPTIN11	4.79e-06	193	153	7	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 MYO9A SYNE1 DAPK1 PARP4 MYH14 SSH2	4.95e-06	194	153	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 MYO9A SYNE1 MYH14 NAV2 CGNL1 CTNND1	4.95e-06	194	153	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 SYNE1 LAMB1 SLC1A3 PRR16 SNED1 PDZRN3	4.95e-06	194	153	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYH9 CENPE LAMB1 PRR16 BRCA1 SEPTIN11 VCL	4.95e-06	194	153	7	78dcb9d48259afabe73b41c5508a73a8d62339a4
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF21 LAMB1 SLC1A3 AKAP12 SNED1 NEO1 VCAN	5.12e-06	195	153	7	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 MYO9A LAMB1 DAPK1 CLCN5 RP1 CGNL1	5.12e-06	195	153	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 MYO9A SYNE1 MYH14 NAV2 CGNL1 CTNND1	5.12e-06	195	153	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF21 LAMB1 SLC1A3 AKAP12 SNED1 NEO1 VCAN	5.12e-06	195	153	7	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF21 LAMB1 SLC1A3 AKAP12 SNED1 NEO1 VCAN	5.12e-06	195	153	7	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK4 ZBTB20 ANK3 KDM4C MYO9A SIPA1L1 NAV2	5.30e-06	196	153	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	MYO9A LAMB3 DAPK1 CLCN5 NAV2 RP1 CGNL1	5.30e-06	196	153	7	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF21 LAMB1 SLC1A3 AKAP12 SNED1 NEO1 VCAN	5.30e-06	196	153	7	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LAMB3 DAPK1 SLC41A2 MYH14 NAV2 MAP7D2 CGNL1	5.48e-06	197	153	7	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK2 SYNE1 LAMB1 SLC1A3 AKAP12 SNED1 PDZRN3	5.48e-06	197	153	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 KDM4C SYNE1 AKAP12 KMT2C AKAP9 LNPEP	5.48e-06	197	153	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK3 PROCA1 LAMB3 SLC41A2 AKAP9 NAV2 GOLGB1	5.48e-06	197	153	7	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	TPR ERCC5 LAMB1 BTN3A2 AKAP9 LNPEP GOLGB1	5.48e-06	197	153	7	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 MAP1B SYNE1 AKAP12 PRR16 NAV2 PDZRN3	5.48e-06	197	153	7	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LAMB1 PRR16 SNED1 VCAN NAV2 SEPTIN11 PDZRN3	5.66e-06	198	153	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK4 ZBTB20 ANK3 KDM4C MYO9A SIPA1L1 NAV2	5.66e-06	198	153	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	TCF21 ANK3 MAP1B MAP2 LAMB1 PRR16 PDZRN3	5.66e-06	198	153	7	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	TCF21 LAMB1 ABCA10 AKAP12 PRR16 SNED1 PDZRN3	5.85e-06	199	153	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DSCAM TRO SYNE1 ATCAY IRF9 VCAN ASTN1	5.85e-06	199	153	7	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1B SYNE1 CNTLN PRR16 PDZRN3 VCL	5.85e-06	199	153	7	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO9A LAMB3 DAPK1 MYH14 NAV2 CGNL1 GOLGB1	5.85e-06	199	153	7	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B ABCA10 AKAP12 VCAN SEPTIN11 ASTN1 CGNL1	5.85e-06	199	153	7	9846d6a31635fde759d55674631c11ab9270a603
Computational	Genes upregulated in subsets of cells of a given type within various tumors	MYH9 SYNE1 SLFN5 AKAP9 GOLGB1	9.55e-05	49	102	5	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Neighborhood of REV3L	TPR FAM91A1 CHD9 MSH3 BRCA1	2.14e-04	58	102	5	MORF_REV3L
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CUL2 CDC42BPA ANK3 DSCAM LAMB1 C11orf24 XRCC4 SP110 AKAP12 SLC17A5 CCDC88C	9.21e-08	197	152	11	4787_DN
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A	STX2 MAP1B LAMB1 SP110 CIC NEK1 STX1A MLH3 SIPA1L1 PLD2	7.88e-07	195	152	10	7432_DN
Drug	Clidinium bromide [3485-62-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	HIVEP2 CDC42BPA IPO8 DSCAM SP110 CIC NEK1 EHBP1L1 WDCP SEPTIN11	7.88e-07	195	152	10	3476_DN
Drug	octafluorotoluene	STX2 STX1A CSF2	1.16e-06	4	152	3	CID000009906
Drug	clotrimazole; Up 200; 50uM; MCF7; HT_HG-U133A_EA	GPRASP1 ANK3 MAP1B XRCC4 MDM4 AKAP9 CLCN5 LNPEP SIPA1L1	4.39e-06	185	152	9	905_UP
Drug	2g6p	MAP1B RASGRF1 MAP2 CHRM2 C2	5.22e-06	38	152	5	CID002740174
Drug	Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; PC3; HT_HG-U133A	CDC42BPA MSH3 ODF2 AKAP12 SLC17A5 EHBP1L1 GTF2I BRCA1 SIPA1L1	5.94e-06	192	152	9	5812_UP
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; HL60; HT_HG-U133A	PPFIA4 ANKRD26 MSH3 MDM4 SP110 STX1A MLH3 GTF2I CLCN5	6.20e-06	193	152	9	2930_DN
Drug	Amphotericin B [1397-89-3]; Down 200; 4.4uM; HL60; HT_HG-U133A	EXO5 ZBTB20 CEP290 ANKRD26 CNTLN ABCG1 CLCN5 LNPEP VCAN	7.02e-06	196	152	9	2441_DN
Drug	Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A	CUL2 STX2 LAMB3 SP110 ABCG1 STX1A MYH14 LNPEP SEPTIN11	7.32e-06	197	152	9	7345_DN
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	STX2 IPO8 ANKRD26 AKAP12 SLC17A5 GTF2I MYH14 NAV2 SEPTIN11	7.32e-06	197	152	9	5835_UP
Drug	Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	STX2 CEP290 SP110 CIC SLC17A5 LNPEP GMEB1 SEPTIN11 USP33	7.32e-06	197	152	9	7231_DN
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	IPO8 DSCAM MYO9A ANKRD26 GON4L LAMB3 CCDC88C GMEB1 PDZRN3	7.32e-06	197	152	9	1674_DN
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A	ANK3 LAMB1 GON4L XRCC4 SP110 GTF2I AKAP9 CLCN5 SIPA1L1	7.62e-06	198	152	9	4790_DN
Drug	0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A	STX2 GPRASP1 ZBTB20 CDC42BPA C11orf24 BTN3A2 PACS1 VCAN PLD2	7.62e-06	198	152	9	6426_UP
Drug	Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A	EXO5 HIVEP2 IPO8 DSCAM LAMB3 SMG5 STX1A NEO1 SEPTIN11	7.62e-06	198	152	9	2640_DN
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A	CDC42BPA ANK3 DSCAM ABCG1 MLH3 NAV2 SEPTIN11 JHY MAP3K19	7.94e-06	199	152	9	3073_UP
Drug	Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A	PRUNE2 CDC42BPA LAMB3 SP110 STX1A SIPA1L1 VCAN SCN10A JHY	7.94e-06	199	152	9	5526_UP
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; PC3; HT_HG-U133A	SETD1A EXO5 CDC42BPA IPO8 CEP290 XRCC4 SLC1A3 PACS1 ASTN1	8.27e-06	200	152	9	4075_DN
Drug	nocodazole	MYH9 MAP1B MAP2 BAG1 MCC TTK AKAP12 ADGRL4 AKAP9 MYH14 CTNND1 GOLGB1 VCL	1.98e-05	477	152	13	CID000004122
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	DOCK4 STX2 MAP1B AKAP12 NEK1 STX1A WDCP VCL	2.91e-05	180	152	8	6579_UP
Drug	Nimodipine [66085-59-4]; Up 200; 9.6uM; HL60; HT_HG-U133A	DOCK4 CDC42BPA ANK3 LAMB3 MSH3 SLC1A3 ABCG1 SIPA1L1	3.54e-05	185	152	8	3103_UP
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	CUL2 MAP1B BAG1 PACS1 SIPA1L1 SCN10A NAV2 VCL	3.67e-05	186	152	8	6793_UP
Drug	2-bromoethyl methyl ether	SYNE1 CSF2	4.43e-05	2	152	2	CID000080972
Drug	N-methyloxazolidine	SYNE1 CSF2	4.43e-05	2	152	2	CID000214264
Drug	Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SLK CDC42BPA AXIN1 ABCG1 BRCA1 MYH14 WDCP GMEB1	4.60e-05	192	152	8	6207_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	DOCK4 STX2 XRCC4 AKAP12 SLC17A5 PSME4 CLCN5 SEPTIN11	4.60e-05	192	152	8	4743_DN
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A	SETD1A MCC ANKRD26 XRCC4 SP110 CCDC88C IRF9 PLD2	4.60e-05	192	152	8	1829_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	TPR CDC42BPA ANK3 PACS1 NEK1 MLH3 AKAP9 ACIN1	4.60e-05	192	152	8	7280_DN
Drug	CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A	STX2 CDC42BPA IPO8 MAP1B C11orf24 AKAP12 NEK1 PDZRN3	4.77e-05	193	152	8	3908_DN
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A	TPR CDC42BPA C11orf24 XRCC4 AXIN1 NEO1 SIPA1L1 GMEB1	4.77e-05	193	152	8	6215_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A	CDC42BPA KDM4C MCC XRCC4 NEK1 STX1A MLH3 SIPA1L1	4.95e-05	194	152	8	3321_DN
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	DOCK4 STX2 UBR2 HIVEP2 DOCK10 GTF2I AKAP9 NAV2	4.95e-05	194	152	8	4662_DN
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	STX2 TPR ZBTB20 ANK3 MAP2 SYNE1 PACS1 VCAN	5.13e-05	195	152	8	7058_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	GPRASP1 IPO8 SYNE1 ANKRD26 GTF2I CLCN5 GMEB1 PLD2	5.13e-05	195	152	8	3778_DN
Drug	Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	STX2 IPO8 GON4L SLC17A5 STX1A GTF2I AKAP9 SEPTIN11	5.32e-05	196	152	8	4993_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CUL2 MCC MDM4 SLC17A5 EHBP1L1 GTF2I PSME4 SEPTIN11	5.32e-05	196	152	8	3206_DN
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; HL60; HT_HG-U133A	CDC42BPA CEP290 MCC DAPK1 CNTLN DNTTIP2 SIPA1L1 PLD2	5.32e-05	196	152	8	1834_UP
Drug	0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A	STX2 TPR SETD1A ANK3 MAP2 SYNE1 PACS1 JHY	5.32e-05	196	152	8	7057_DN
Drug	deferoxamine mesylate salt; Down 200; 100uM; MCF7; HG-U133A	CDC42BPA DSCAM CENPE AXIN1 EHBP1L1 CLCN5 GMEB1 AMOTL2	5.32e-05	196	152	8	485_DN
Drug	Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SLK IPO8 DSCAM SMG5 PACS1 BRCA1 WDCP PLD2	5.52e-05	197	152	8	3212_DN
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A	CUL2 MAP1B INTS1 MCC GON4L SMG5 CCDC88C AKAP9	5.52e-05	197	152	8	3235_DN
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	CDC42BPA IPO8 XRCC4 MDM4 SLC17A5 MYH14 VCAN JHY	5.52e-05	197	152	8	6607_DN
Drug	Androsterone [53-41-8]; Up 200; 13.8uM; PC3; HT_HG-U133A	SETD1A IPO8 MAP1B MAP2 ABCG1 VCAN SCN10A GMEB1	5.52e-05	197	152	8	4635_UP
Drug	Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	CDC42BPA DSCAM ANKRD26 MDM4 SP110 IRF9 CLCN5 GMEB1	5.52e-05	197	152	8	5335_UP
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; PC3; HT_HG-U133A	ZBTB20 CDC42BPA IPO8 DOCK10 GON4L XRCC4 AXIN1 MYH14	5.52e-05	197	152	8	4091_DN
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CUL2 STX2 CDC42BPA DSCAM SP110 CIC ABCG1 CLCN5	5.52e-05	197	152	8	1693_DN
Drug	S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	CUL2 LAMB1 ODF2 MDM4 PACS1 BRCA1 SIPA1L1 ACIN1	5.52e-05	197	152	8	5694_DN
Drug	Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	STX2 CENPE INTS1 LAMB1 XRCC4 SP110 ABCG1 GOLGB1	5.52e-05	197	152	8	7185_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A	DMTF1 C11orf24 SMG5 XRCC4 AXIN1 CLCN5 BRCA1 VCAN	5.52e-05	197	152	8	2060_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A	CEP290 SLC1A3 AXIN1 CCDC88C GTF2I CLCN5 VCAN GMEB1	5.52e-05	197	152	8	4216_DN
Drug	Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A	GCFC2 CDC42BPA LAMB1 SP110 AXIN1 MLH3 GTF2I PRPF39	5.52e-05	197	152	8	6251_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	STX2 HIVEP2 CDC42BPA CEP290 ODF2 PACS1 GTF2I SEPTIN11	5.72e-05	198	152	8	3754_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A	IPO8 DSCAM ANKRD26 ODF2 MDM4 SP110 STX1A SEPTIN11	5.72e-05	198	152	8	4995_DN
Drug	Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A	SETD1A GON4L SMG5 SP110 CIC ABCG1 STX1A PLD2	5.72e-05	198	152	8	3305_DN
Drug	Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A	SETD1A MYH9 LAMB1 NEK1 EHBP1L1 NAV2 PLD2 PDZRN3	5.72e-05	198	152	8	2809_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A	MAP1B CEP290 XRCC4 AXIN1 CCDC88C PACS1 NEK1 GTF2I	5.72e-05	198	152	8	6269_DN
Drug	PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A	IPO8 DOCK10 SMG5 SLC17A5 PACS1 ABCG1 KRT24 LNPEP	5.72e-05	198	152	8	6550_UP
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	STX2 DSCAM KDM4C XRCC4 SP110 EHBP1L1 BRCA1 GMEB1	5.72e-05	198	152	8	7514_DN
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A	SMG5 MSH3 SP110 CIC AKAP12 AXIN1 CCDC88C GMEB1	5.72e-05	198	152	8	3434_DN
Drug	Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A	HIVEP2 CDC42BPA KDM4C AXIN1 CLCN5 BRCA1 VCAN PLD2	5.72e-05	198	152	8	7381_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	CDC42BPA MAP2 INTS1 XRCC4 STX1A MYH14 VCAN SCN10A	5.72e-05	198	152	8	5220_UP
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	HIVEP2 CEP290 ODF2 SLC1A3 BTN3A2 SLC17A5 MLH3 CLCN5	5.72e-05	198	152	8	2069_DN
Drug	Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A	CUL2 MYH9 ANK3 ANKRD26 GON4L XRCC4 ABCG1 MLH3	5.92e-05	199	152	8	1500_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MYH9 GCFC2 MYO9A XRCC4 MLH3 PSME4 WDR11 TRMT1L	5.92e-05	199	152	8	1055_DN
Drug	PF-01378883-00 [351320-41-7]; Down 200; 10uM; PC3; HT_HG-U133A	IPO8 DSCAM ANKRD26 GON4L NEK1 ABCG1 KRT24 SCN10A	5.92e-05	199	152	8	6410_DN
Drug	Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A	CUL2 CDC42BPA IPO8 DSCAM SMG5 CIC PACS1 LNPEP	5.92e-05	199	152	8	7233_DN
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	UBR2 MYO9A CEP290 SP110 PACS1 MLH3 GMEB1 SEPTIN11	5.92e-05	199	152	8	1484_DN
Drug	Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A	HIVEP2 IPO8 CEP290 SMG5 XRCC4 IRF9 STX1A PSME4	6.14e-05	200	152	8	7129_DN
Drug	Sulfapyridine [144-83-2]; Down 200; 16uM; PC3; HT_HG-U133A	STX2 SMG5 ODF2 XRCC4 NEK1 AKAP9 BRCA1 NAV2	6.14e-05	200	152	8	7151_DN
Drug	haloperidol; Up 200; 10uM; HL60; HT_HG-U133A	PRUNE2 CUL2 ZBTB20 TRO INTS1 SLC1A3 PACS1 MYH14	6.14e-05	200	152	8	2704_UP
Drug	AC1NBNXD	MAP1B MAP2 CHRM2	7.94e-05	13	152	3	CID004470981
Drug	1ec0	GTF2IRD2B ABCG1 GTF2I GTF2IRD2	1.18e-04	38	152	4	CID000445306
Drug	zoledronic acid	SMIM24 PRUNE2 SETD1A ERCC5 ANK2 MAP2 BAG1 DOCK10 LAMB1 LAMB3 DAPK1 MSH3 SLFN5 MDM4 TTK SLC1A3 GTF2I CSF2 CLCN5 LNPEP NAV2 CGNL1 SSH2	1.19e-04	1472	152	23	ctd:C088658
Drug	decyl disulfide	STX2 STX1A	1.32e-04	3	152	2	CID000139170
Drug	Sas 1	LAMB1 SLC17A5 CSF2	1.53e-04	16	152	3	CID006328170
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA	STX2 MAP1B AKAP12 SLC17A5 NEK1 WDCP VCL	1.91e-04	177	152	7	1072_UP
Drug	Hexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A	DOCK4 GPRASP1 SP110 PACS1 IRF9 SIPA1L1 VCAN	2.51e-04	185	152	7	2457_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	GPRASP1 ANK3 DSCAM CEP290 ANKRD26 AKAP9 MYH14	2.59e-04	186	152	7	1664_UP
Drug	colchine	STX2 MAP2 ATCAY LAMB1 CHRM2 SLC17A5 STX1A CSF2 VCAN VCL	2.61e-04	383	152	10	CID000002833
Drug	N-methyl-1(R)-aminoindan	CCDC6 TTK GTF2IRD2B STX1A GTF2I GTF2IRD2	2.63e-04	132	152	6	CID005494442
Drug	benzylfluoride	SYNE1 CSF2	2.63e-04	4	152	2	CID000009591
Drug	naftifine	SYNE1 CIC	2.63e-04	4	152	2	CID000047641
Drug	botulinum toxin type C	STX1B STX1A	2.63e-04	4	152	2	ctd:C096324
Drug	Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	SP110 IRF9 AKAP9 SIPA1L1 SCN10A NAV2 PLD2	2.76e-04	188	152	7	5490_UP
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	TPR IPO8 MAP1B ODF2 XRCC4 GMEB1 SEPTIN11	2.85e-04	189	152	7	3788_DN
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	IPO8 MCC XRCC4 AXIN1 GTF2I BRCA1 SEPTIN11	2.85e-04	189	152	7	6717_DN
Drug	Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A	STX2 SETD1A KDM4C ANKRD26 PACS1 PLD2 JHY	2.95e-04	190	152	7	5614_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	EXO5 ANKRD26 LAMB1 CIC AKAP12 BRCA1 SIPA1L1	3.04e-04	191	152	7	5200_DN
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CUL2 EXO5 CEP290 AKAP12 IRF9 STX1A GMEB1	3.04e-04	191	152	7	7165_UP
Drug	CV-6209	STX2 STX1A CSF2	3.06e-04	20	152	3	CID000107756
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	CENPE LAMB1 MSH3 AKAP12 STX1A AKAP9 PDZRN3	3.14e-04	192	152	7	2865_DN
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A	UBR2 EXO5 CDC42BPA IPO8 MAP1B XRCC4 SEPTIN11	3.24e-04	193	152	7	6938_UP
Drug	Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A	ZBTB20 CDC42BPA ANK3 MAP1B MAP2 SYNE1 PLD2	3.24e-04	193	152	7	7059_DN
Drug	Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; PC3; HT_HG-U133A	ANK3 KDM4C PPFIA4 MCC PRR16 SLC17A5 NAV2	3.24e-04	193	152	7	4671_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	STX2 MAP1B CEP290 SMG5 SP110 LNPEP PLD2	3.34e-04	194	152	7	7214_DN
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A	IPO8 ANK3 SMG5 XRCC4 GTF2I CLCN5 SIPA1L1	3.34e-04	194	152	7	2632_DN
Drug	Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CUL2 CDC42BPA ANKRD26 SP110 PACS1 NEK1 PLD2	3.34e-04	194	152	7	7479_DN
Drug	Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A	ZBTB20 SYNE1 ANKRD26 SMG5 XRCC4 BTN3A2 JHY	3.34e-04	194	152	7	6656_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A	SLK CENPE CHD9 TTK CIC VCAN PRPF39	3.34e-04	194	152	7	1715_DN
Disease	Colorectal Carcinoma	CPAMD8 ANK2 MAP1B MAP2 SYNE1 MCC LAMB3 ABCA10 AKAP12 KMT2C ABCG1 MLH3 CSF2 AKAP9 ACIN1 SESN2	5.80e-07	702	149	16	C0009402
Disease	Substance abuse problem	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11 ASTN1	2.14e-06	116	149	7	C0740858
Disease	Intellectual Disability	SETD1A HIVEP2 MAP1B SYNE1 MCC GON4L CIC PACS1 KMT2C BRCA1 ACIN1 ASTN1	3.08e-06	447	149	12	C3714756
Disease	Malignant neoplasm of breast	MYH9 ANK2 SYNE1 BAG1 MDM4 SP110 BTN3A2 CIC AKAP12 CSF2 AKAP9 BRCA1 WDCP SIPA1L1 MAP7D2 BOD1L1 PLD2 GOLGB1	8.57e-06	1074	149	18	C0006142
Disease	autosomal recessive intellectual developmental disorder (is_implicated_in)	TPR WDR11	2.53e-05	2	149	2	DOID:0060308 (is_implicated_in)
Disease	Drug habituation	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C0013170
Disease	Drug abuse	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C0013146
Disease	Prescription Drug Abuse	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C4316881
Disease	Substance-Related Disorders	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C0236969
Disease	Drug Use Disorders	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C0013222
Disease	Drug Dependence	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C1510472
Disease	Substance Dependence	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C0038580
Disease	Substance Use Disorders	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C0038586
Disease	Organic Mental Disorders, Substance-Induced	SLK DSCAM SYNE1 CHRM2 PACS1 WDR11	2.68e-05	115	149	6	C0029231
Disease	Romano-Ward Syndrome	ANK2 AKAP9 SCN10A	6.73e-05	16	149	3	C0035828
Disease	disease of mental health (implicated_via_orthology)	CIC STX1A	7.57e-05	3	149	2	DOID:150 (implicated_via_orthology)
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	MSH3 XRCC4 MLH3	1.15e-04	19	149	3	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	MSH3 XRCC4 MLH3	1.15e-04	19	149	3	C2936783
Disease	Endometrial cancer	MSH3 MLH3	1.51e-04	4	149	2	cv:C0007103
Disease	ENDOMETRIAL CANCER	MSH3 MLH3	1.51e-04	4	149	2	608089
Disease	Endometrial carcinoma	MSH3 MLH3	1.51e-04	4	149	2	cv:C0476089
Disease	Sarcoma	MDM4 CIC CSF2	1.57e-04	21	149	3	C1261473
Disease	Schizophrenia	DOCK4 SETD1A ANK3 BAG1 CMYA5 XRCC4 CHRM2 SLC1A3 STX1A CSF2 BRCA1 WDR11 SEPTIN11 CGNL1	1.62e-04	883	149	14	C0036341
Disease	Bipolar Disorder	ANK3 DSCAM RASGRF1 MAP2 SYNE1 BAG1 CHRM2 SLC1A3 PACS1 SEPTIN11	1.64e-04	477	149	10	C0005586
Disease	Alzheimer's disease (implicated_via_orthology)	HIVEP2 ANK2 MAP2 TOMM40	2.00e-04	57	149	4	DOID:10652 (implicated_via_orthology)
Disease	Epilepsy	SETD1A CHRM2 SLC1A3 STX1B ASTN1	2.35e-04	109	149	5	C0014544
Disease	Brugada Syndrome (disorder)	ANK2 AKAP9 SCN10A	2.36e-04	24	149	3	C1142166
Disease	stomach carcinoma (is_marker_for)	KDM4C KMT2C BRCA1	2.36e-04	24	149	3	DOID:5517 (is_marker_for)
Disease	cerebellar ataxia (is_implicated_in)	SYNE1 ATCAY	2.51e-04	5	149	2	DOID:0050753 (is_implicated_in)
Disease	Hereditary Nonpolyposis Colorectal Neoplasms	MSH3 XRCC4 MLH3	3.01e-04	26	149	3	C0009405
Disease	Hereditary non-polyposis colorectal cancer syndrome	MSH3 XRCC4 MLH3	3.38e-04	27	149	3	C1112155
Disease	neuroimaging measurement	CDC42BPA ANK3 MAP1B MAP2 KIF1B XRCC4 CCDC88C NEO1 BRCA1 VCAN SYCP1 NAV2 TOMM40 SSH2 PDZRN3	3.50e-04	1069	149	15	EFO_0004346
Disease	cup-to-disc ratio measurement	ANK3 ZC3H11B DAPK1 EHBP1L1 CSF2 VCAN NAV2 CTNND1 AMOTL2	3.53e-04	430	149	9	EFO_0006939
Disease	Hereditary Nonpolyposis Colorectal Cancer	MSH3 XRCC4 MLH3	4.19e-04	29	149	3	C1333990
Disease	bipolar disorder (is_implicated_in)	ANK3 SYNE1 CHRM2	4.19e-04	29	149	3	DOID:3312 (is_implicated_in)
Disease	juvenile myelomonocytic leukemia (is_implicated_in)	AKAP12 CSF2	5.23e-04	7	149	2	DOID:0050458 (is_implicated_in)
Disease	Colorectal Neoplasms	CPAMD8 SYNE1 ABCA10 ABCG1 MLH3 CSF2 SESN2	5.38e-04	277	149	7	C0009404
Disease	intellectual disability (implicated_via_orthology)	HIVEP2 ANK2 CAPN11 BOD1L1	5.75e-04	75	149	4	DOID:1059 (implicated_via_orthology)
Disease	neutrophil count	PRUNE2 UBR2 CPAMD8 HIVEP2 CDC42BPA DSCAM KIF1B CHD9 CIC AKAP12 ADGRL4 BRCA1 LNPEP SYCP1 RP1 SSH2 RAB37	6.34e-04	1382	149	17	EFO_0004833
Disease	visceral heterotaxy (implicated_via_orthology)	CEP290 DRC1 PSME4	8.64e-04	37	149	3	DOID:0050545 (implicated_via_orthology)
Disease	heart rate variability measurement	CHRM2 NEO1 SIPA1L1	8.64e-04	37	149	3	EFO_0008003
Disease	Cataract	CPAMD8 MYH9 INTS1	8.64e-04	37	149	3	C0086543
Disease	PR interval	DOCK4 TCF21 CHRM2 PRR16 CSF2 SIPA1L1 SCN10A NAV2 PDZRN3	9.62e-04	495	149	9	EFO_0004462
Disease	Proteinuria	MYH9 MUC16 CLCN5	1.34e-03	43	149	3	C0033687
Disease	nucleus accumbens volume change measurement	DSCAM MUC16	1.35e-03	11	149	2	EFO_0021493
Disease	esophagus squamous cell carcinoma (is_implicated_in)	KDM4C KMT2C BRCA1	1.53e-03	45	149	3	DOID:3748 (is_implicated_in)
Disease	Adenoid Cystic Carcinoma	DAPK1 KMT2C BRCA1 VCAN	1.68e-03	100	149	4	C0010606
Disease	Leukemia, Myelocytic, Acute	DAPK1 KMT2C GTF2I CSF2 BRCA1	1.90e-03	173	149	5	C0023467
Disease	mental or behavioural disorder	DMTF1 KDM4C MCC DAPK1 CMYA5	2.20e-03	179	149	5	EFO_0000677
Disease	R-warfarin measurement	DOCK4 HIVEP2 ANK2 CHRM2 STX1B SCN10A	2.34e-03	265	149	6	EFO_0803324
Disease	macula measurement	CDC42BPA MYO9A TTK NAV2 CGNL1	2.78e-03	189	149	5	EFO_0008375
Disease	hippocampal atrophy	PRUNE2 GCFC2 TOMM40	2.88e-03	56	149	3	EFO_0005039
Disease	Polyposis, Adenomatous Intestinal	MCC MSH3	2.90e-03	16	149	2	C2713442
Disease	Familial Intestinal Polyposis	MCC MSH3	2.90e-03	16	149	2	C2713443
Disease	coronary artery disease	SLK HIVEP2 ZBTB20 TCF21 DSCAM MAP1B AKAP12 KIAA0319 EHBP1L1 LNPEP C2 TOMM40 RP1 RAB37	2.98e-03	1194	149	14	EFO_0001645
Disease	Adenomatous Polyposis Coli	MCC MSH3	3.28e-03	17	149	2	C0032580
Disease	cortical surface area measurement	CPAMD8 ANK3 MAP2 KIF1B DOCK10 DAPK1 CNTLN AXIN1 CCDC88C NEO1 VCAN NAV2 SSH2 PLS1 PDZRN3	3.40e-03	1345	149	15	EFO_0010736
Disease	Acute Myeloid Leukemia, M1	DAPK1 KMT2C GTF2I CSF2	3.77e-03	125	149	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	DAPK1 KMT2C GTF2I CSF2	3.77e-03	125	149	4	C1879321
Disease	puberty onset measurement	KDM4C GTF2I SMC1B JHY	3.77e-03	125	149	4	EFO_0005677
Disease	FEV/FEC ratio	STX2 MYH9 HIVEP2 TCF21 MAP2 KIF1B MCC ZC3H11B SLC1A3 GTF2I CSF2 NAV2 SSH2 PDZRN3	3.82e-03	1228	149	14	EFO_0004713
Disease	Phenyllactate (PLA) measurement	IPO8 DAPK1	4.09e-03	19	149	2	EFO_0021662
Disease	Chronic myeloproliferative disorder	CENPE XRCC4	4.09e-03	19	149	2	C1292778
Disease	white matter integrity	SLK CCDC88C VCAN C2	4.34e-03	130	149	4	EFO_0004641
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	MAP2 DAPK1 BEND2 SIPA1L1	4.46e-03	131	149	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	MAP2 DAPK1 BEND2 SIPA1L1	4.46e-03	131	149	4	C4552091
Disease	Juvenile arthritis	MAP2 DAPK1 BEND2 SIPA1L1	4.46e-03	131	149	4	C3495559
Disease	Juvenile psoriatic arthritis	MAP2 DAPK1 BEND2 SIPA1L1	4.46e-03	131	149	4	C3714758
Disease	Adenocarcinoma of prostate	AXIN1 BRCA1	4.53e-03	20	149	2	C0007112
Disease	language measurement	ANK3 DOCK10 GON4L CGNL1	4.83e-03	134	149	4	EFO_0007797
Disease	Juvenile-Onset Still Disease	MAP2 DAPK1 BEND2 SIPA1L1	4.96e-03	135	149	4	C0087031
Disease	schizophrenia (implicated_via_orthology)	SETD1A HIVEP2 ASTN1	4.98e-03	68	149	3	DOID:5419 (implicated_via_orthology)
Disease	HIV-1 infection, Susceptibility to viral and mycobacterial infections	KDM4C NAV2	4.99e-03	21	149	2	EFO_0000180, Orphanet_391311

Protein segments in the cluster

Peptide	Gene	Start	Entry
VEEKEEVTMDTSENR	ACIN1	766	Q9UKV3
EEEERVISSVISVSM	ADGRL4	326	Q9HBW9
MEESEDSQSDSQTRI	C2orf16	1046	Q68DN1
DSVATSRVQDLSDMV	AMOTL2	761	Q9Y2J4
SNMSVARSDDTLDEE	DAPK1	326	P53355
VDSVVITESDAQRTM	AKAP9	1386	Q99996
SSEEMESQLQERVES	RNF20	166	Q5VTR2
QSEREMTDSTPVFTE	VCAN	1781	P13611
MSGDERSDEIVLTVS	CTCFL	206	Q8NI51
VSRISETESAMAEIE	CNTLN	1231	Q9NXG0
TELIQMESTSFSRDD	ABCA10	911	Q8WWZ4
VSVDEVVSSNMEATE	ABCG1	31	P45844
TMLEVTDESAQRVTA	ADGRG4	866	Q8IZF6
GSSVVAEETEVTMSE	ADGRG4	1021	Q8IZF6
TEASAAEETTEMVSA	AKAP12	991	Q02952
FVRTEETATEMLTSE	AKAP12	1561	Q02952
EESTRSEEVTREEMA	BAG1	126	Q99933
MRDDEITQDENTVST	CHRM2	296	P08172
QLSESESSLEMDDER	CCDC6	321	Q16204
MDDVDDLTQSSETAS	ANKRD26	681	Q9UPS8
IEVTSDSELESMTDK	CAPN11	276	Q9UMQ6
MSTVEEDSDTVTVET	DMTF1	1	Q9Y222
EVTMTATTEVADDEV	DMTF1	86	Q9Y222
SVMVRTEEEISDTDL	DMTF1	646	Q9Y222
EDAVEVREELMTSSS	ASTN1	581	O14525
VREELMTSSSFDSLE	ASTN1	586	O14525
EVESRDLMSSSDEST	CCDC83	301	Q8IWF9
TSEVMDTQAGSVDEE	ASH2L	91	Q9UBL3
REERSGMTTDDDAVS	PDZRN3	951	Q9UPQ7
DMSSERVIRSEDGET	RAB37	146	Q96AX2
MTSEKNDETESTETS	ANK2	1471	Q01484
SAEDDSLEQTSLMES	ANK2	2516	Q01484
MAETREEETVSAEAS	EXO5	1	Q9H790
ARTQDFVDSETTSVM	MUC16	6186	Q8WXI7
EILTTDEDTTAIEAM	MUC16	6866	Q8WXI7
ERLTTLEDTVDTEDM	MUC16	8331	Q8WXI7
DDAVNVDEIMTDTST	MSH3	351	P20585
NTDLSEDSERVMIIT	MSH3	881	P20585
MIDAVVTSRSEDDET	PATL1	496	Q86TB9
EDSMDGLETTETETI	KMT2C	66	Q8NEZ4
SDEAVSTEVRLMITD	MAP1B	116	P46821
DSLESDSESLTQEIM	JHY	41	Q6NUN7
DSSLTDTRETSEEMQ	NEK1	686	Q96PY6
SLDDSTEEVQSMDVS	MAP7D2	636	Q96T17
SITQIAISEESMEEA	GMEB1	211	Q9Y692
TLTDEETRTEMLNRE	INTS1	781	Q8N201
SESQETISSMGEQLD	MDM4	401	O15151
EMASSAQDESETTVT	KIF1B	861	O60333
AEEIETRVTSGSMEA	PPFIA4	601	O75335
EEMETLETSTKTDSE	PPFIA4	916	O75335
ENRSALVSEDQETSM	ATCAY	356	Q86WG3
DNSRDMTEVISSLEN	C2	311	P06681
STESFEMVIEEATID	FAM91A1	691	Q658Y4
IEMVEVSETADNSTN	BEND2	26	Q8NDZ0
EETTDDELGTNIDTM	CARMIL3	891	Q8ND23
SSEMVTLEEFLEESN	CCDC88C	1666	Q9P219
DVTESAESMNREVTT	MYH14	1926	Q7Z406
MENSTTTISREELEE	PLS1	1	Q14651
MRQDNRDTVDDTVSS	MLH3	1121	Q9UHC1
IDEATASIDMETDTL	ABCC11	1301	Q96J66
SEMLGTQETEVEASR	EHBP1L1	696	Q8N3D4
EASSEEESSASRMQV	KDM4C	426	Q9H3R0
TRSDLEMQIESFTEE	KRT24	261	Q2M2I5
QMSLEAEERVNASTT	LAMB1	1326	P07942
SSSVQSSEQIEEMFD	LNPEP	531	Q9UIQ6
EDATETADAMNREVS	MYH9	1901	P35579
EEVMNSSTLSQEVSD	PARP4	251	Q9UKK3
SMEETSTRSELELAE	DRC1	576	Q96MC2
STRSELELAEQTEME	DRC1	581	Q96MC2
VNASTEETEMASAVD	PRPF39	51	Q86UA1
SLTETDTLEITDQDM	PACS1	451	Q6VY07
EVNHSRETSIEMEES	BRCA1	836	P38398
EVVTSDSMEEGEITS	BOD1L1	426	Q8NFC6
TEENMEGTRVTTEEF	BOD1L1	2101	Q8NFC6
SETNSTTSRVMEEKD	BOD1L1	2826	Q8NFC6
PQSSEEESMSSVETR	CHD9	2056	Q3L8U1
EDSRSMDQDQTSVSI	MCC	126	P23508
SRDTAAEMNETVEVI	CSF2	46	P04141
VESIDSISETNMDFT	GABRR3	91	A8MPY1
EIDMDQTSLSLNSED	GABRR3	391	A8MPY1
LTETEDTVKTTRNME	DOCK10	341	Q96BY6
TEDSVITEMTSTLRD	DOCK4	81	Q8N1I0
RMAEESISRNEETSE	GCFC2	201	P16383
EMADIVEASRTSTLE	CGNL1	956	Q0VF96
MEQTVAEQDDSLSSL	CEP290	1626	O15078
NVSEAMETLTRITEE	SLC1A3	216	P43003
VSDMELSETETRSQR	AXIN1	756	O15169
SVNVAESMSRESDIS	CMYA5	2561	Q8N3K9
DRVSQSVVSAEVEMT	CPAMD8	1366	Q8IZJ3
DSMTVEDVETIISET	CLCN5	671	P51795
KSRLRQSSEMTETDE	GON4L	406	Q3T8J9
QSSEMTETDEESGIL	GON4L	411	Q3T8J9
MTENEVEDRLTSFIT	CUL2	406	Q13617
MQSELSDEEESTSRN	ANK3	4021	Q12955
EITALSSEIESEQEM	BTN3A2	276	P78410
SSVSSERKEEEDAMQ	IRF9	136	Q00978
ETQVSASRSQMEEDV	LAMB3	871	Q13751
VEEESSSETRMVVTF	GTF2IRD2	11	Q86UP8
VEEESSSETRMVVTF	GTF2IRD2B	11	Q6EKJ0
MSTLPVEDEESSESR	GTF2I	6	P78347
VEDEESSESRMVVTF	GTF2I	11	P78347
DMVDSNTTLEDNRTS	SLC17A5	66	Q9NRA2
RMSESSPESREELES	PROCA1	291	Q8NCQ7
MNESTEFEERSATIS	CENPE	2311	Q02224
MDDSEVESTASILAS	CTNND1	1	O60716
EEVSMEESTGDRDIS	MAP3K19	811	Q56UN5
ETVTRLEQSLSEAME	CNTROB	276	Q8N137
SVMRLSDLSTEDDDS	ODF2	101	Q5BJF6
TMDELSSSELEELTQ	RP1	1796	P56715
ISSDEEETNVTAQAM	IPO8	901	O15397
MTEAITEAAVASSEE	MROH2A	1	A6NES4
ERDTMETIDDRSTVL	DSCAM	1671	O60469
SMADEASIESSLQVE	GPRASP1	416	Q5JY77
SLLRDEGTSQEEMES	SESN2	271	P58004
QSASEDTVTERVEMS	TRMT1L	706	Q7Z2T5
TRTRMDEEVSDPTSA	UVSSA	446	Q2YD98
EITESSSTEEMEVRS	SLK	641	Q9H2G2
SSTEEMEVRSVVADT	SLK	646	Q9H2G2
EDTQSTATISDMDND	PRUNE2	1121	Q8WUY3
TDEETVAEINATMSV	SEPTIN11	216	Q9NVA2
ETDSEMNSQESRSDL	SMG5	511	Q9UPR3
SHSSDLSTIQERMEE	SYNE1	7381	Q8NF91
ASTSDEEEITMLSQN	PWWP3B	106	Q5H9M0
LTSDLQLEDEMTDSS	PRR16	61	Q569H4
AEEMRINSSTENSDE	ERCC5	416	P28715
EVQETTRMLEDSESS	NEO1	1421	Q92859
ESEELEAASRMLTTV	NAV2	461	Q8IVL1
SSEVISMADRTLETE	SIPA1L1	1366	O43166
AEDEEETTFRMESNL	SMIM24	61	O75264
RETSETTAMLQDEDI	SLC41A2	121	Q96JW4
SRSEEIIDGTSEMNE	SP110	346	Q9HB58
SQVIDMRDEEFSVSS	CDC42BPA	1131	Q5VT25
KQSSEVSMREESDID	RASGRF1	831	Q13972
LASDTEEEEENSSMV	SETD1A	506	O15047
GRTTTDDELEEMLES	STX2	156	P32856
SRTADMAEVETTTNV	SNED1	231	Q8TER0
TSMQVADRVLSTDVD	ABHD10	256	Q9NUJ1
SQRAASEDMTSDEER	CIC	426	Q96RK0
SMEVTTEDTSRTDVS	C11orf24	76	Q96F05
EESTVISVSEDMNSE	DNTTIP2	401	Q5QJE6
SEESSMDEEQSKAIS	SSH2	716	Q76I76
DIQTETTEEDSVLLM	TRO	31	Q12816
IEVEMGTEAESTQAT	SMC1B	951	Q8NDV3
MEDSEETSQSLQIDL	TPR	1906	P12270
TSSSIQNEDEATSME	SCN10A	1936	Q9Y5Y9
ETTDLLSMVSEEETL	SYCP1	896	Q15431
TGRTTTSEELEDMLE	STX1A	156	Q16623
GRTTTNEELEDMLES	STX1B	156	P61266
SSEDSDITSLIEAMD	TMEM131	1341	Q92545
TVSESEISQEADDMA	XRCC4	46	Q13426
RTNISDEESEQATEM	VCL	1076	P18206
MSTGSLSDVEDLQEV	TCF21	1	O43680
STLEQTREETETEKM	PSME4	561	Q14997
TREETETEKMTHLES	PSME4	566	Q14997
SDTRESVHESIDTMS	MAP2	596	P11137
SSPERSNEVEMDSTV	ZBTB20	431	Q9HC78
RMEATEASVETTGVD	ZC3H11B	536	A0A1B0GTU1
VEFEASTRMQDTSVS	TOMM40	286	O96008
RRLAAQESSETEDMS	WASHC2A	1046	Q641Q2
MESEDLSGRELTIDS	TTK	1	P33981
NNSRISDDITDMISE	ZGRF1	491	Q86YA3
EAMARQTVVSDTELS	WDR11	636	Q9BZH6
EVRSMDKEATDSETN	WDCP	256	Q9H6R7
SMTSVDDTETEEAEN	HIVEP2	1861	P31629
VAETEGTIMEESSRD	UBR2	1011	Q8IWV8
DSSQLQMESDEVDTL	PLD2	16	O14939
ERTSTDVMDSQEALA	SLFN5	121	Q08AF3
ITTEETMEEDKSQSD	USP33	301	Q8TEY7
DEMISVEESSGNTDV	ZNF662	161	Q6ZS27
ETEEQDSLSMSTRPT	GOLGB1	1796	Q14789
LMVSESEFDSDQDTI	KIAA0319	1026	Q5VV43
VSEETLTSEAAMETD	MYO9A	2306	B2RTY4
LTSEAAMETDITEQQ	MYO9A	2311	B2RTY4